The Street Reports

[AveragePenny]

"Signing Day Sports, Inc. (NYSE American: SGN) Soars in Pre-Market on Acquisition News – see more penny stocks inside…."

Article Link: https://www.benzinga.com/pressreleases/24/09/ab40946727/signing-day-sports-inc-nyse-american-sgn-soars-in-pre-market-on-acquisition-news-see-more-penny-s

This article spotlights some of the most promising companies that are gaining traction and driving penny stock market interest, showcasing how their strategic moves are setting them up for future success.

Signing Day Sports, Inc. BIEI: is soaring after announcing a strategic acquisition of Swifty Global, a sports and casino technology company. The acquisition will allow Signing Day Sports to leverage Swifty's scalable tech and gaming licenses to enhance its product offerings and expand into new markets. This move marks a key step in its growth strategy, boosting its position in the global sports tech space.

Premier Graphene Inc. HALB: in partnership with HGI Industrial Technologies and Defense Atomics, is advancing the use of graphene in ballistic protection solutions. This collaboration has the potential to revolutionize personal and tactical equipment for military and government entities, with the partnership expected to generate over $50 million in revenue.

Freight Technologies, Inc. RJDG: recently secured a contract with Bayer AG’s BAYRY CropScience LP to provide cross-border truckload services. This win further solidifies Fr8App's position as a leader in logistics management, offering advanced tech solutions to optimize supply chains and enhance cross-border transportation efficiency for major global players.

Halberd Corporation SPZI: is making strides in brain injury and PTSD treatment through its partnership with Defense Atomics and Athena Telemedicine Partners. With funding secured for advanced research and pilot studies involving veterans, Halberd is poised to deliver cutting-edge solutions using CRISPR technology and its LDX PTSD and brain injury protocol.

RJD Green Inc.'s CBDW: diversified portfolio in healthcare, construction, and environmental services is driving impressive revenue growth. With strategic acquisitions and expanding market reach, RJDG is rapidly gaining traction in multiple high-demand sectors.

JP 3E Holdings, Inc. SPZI: has successfully completed its first shipment of 500 metric tons of Aluminum Ingot through its Trade Finance platform in collaboration with Bloxcross. This milestone highlights the company's growing presence in the global commodities market, positioning it for further expansion and success in the fast-moving aluminum sector.

1606 Corp. CBDW is acquiring a strategic stake in Adnexus Biotechnologies, a leader in AI-driven drug discovery. This partnership integrates Adnexus's advanced AI platform, SUTRA, into 1606's portfolio, enabling the development of breakthrough treatments for infectious and neurological diseases. The collaboration strengthens 1606 Corp.'s commitment to revolutionizing healthcare through AI innovation

[AveragePenny]

$DDDX 3D PRINTING FINALLY READY FOR PREDICTED EXPLOSIVE GROWTH

Article Link: https://richardacavalli.wixsite.com/greenplanetmicrocaps/3d-printing-to-explode
AI CHAT GPT CONFIRMS DORMANT 3D PRINTING STOCKS MAY NOW BE READY FOR EXPLOSIVE GROWTH
Several years ago, 3D Printing stocks started out with a bang but then fizzled . . . Now AI ChatGPT tells us that 3D printing stocks are about to explode
Lower-cost additive manufacturing, major advancements in materials, greater precision, and faster production are now making 3D printing a better choice for manufacturing and point to robust growth for the near and the long term
In-depth searching for potential investment opportunities in the 3D printing sector revealed several promising companies, but one in particular stands out as undervalued, under-followed, and positioned for exceptional growth 
3DX Industries is one of only two or three companies that are selling under $1/share and are down from over 30 cents in 2021 to a current price of just under 2 cents with a total market cap of under $2 million

One of 3DX Industries Advanced 3D Printers
ChatGPT has proven to be a very powerful AI tool and is rapidly providing users with far more useful information than ever available with only Google searches.
We asked ChatGPT, “Is the future for 3D printing explosive?” and we got the following reply:
“Yes, the future for 3D printing is often described as "explosive" due to its rapidly growing impact across various industries and its potential to revolutionize traditional practices. Here's why:
Technological Advancements: The field of 3D printing is advancing quickly, with new materials, faster printing speeds, and more precise technologies continually emerging. This rapid evolution makes it a highly dynamic and transformative area.
2.Diverse Applications: From medical implants and prosthetics to aerospace parts and architectural models, the versatility of 3D printing is leading to groundbreaking applications. The technology's ability to create complex, customized objects is expanding its use across numerous fields.
Economic Impact: 3D printing is poised to disrupt traditional manufacturing by enabling more cost-effective, on-demand production. This shift could reduce the need for large inventories, lower production costs, and streamline supply chains.
Personalization and Customization: The technology allows for high levels of customization, which is increasingly demanded by consumers. This capability can lead to personalized products in sectors like healthcare, fashion, and consumer goods.
Sustainability: 3D printing has the potential to reduce waste by using only the material needed to build an object. This can lead to more sustainable manufacturing practices and lower environmental impact.
Innovation in Materials: Research is continuously expanding the range of materials that can be used in 3D printing, including metals, ceramics, and even biological materials. This opens up new possibilities for applications and industries.
The combination of these factors creates a scenario where the impact of 3D printing could be transformative on a global scale, leading many to view its future as not just promising but truly explosive in terms of potential and disruption.
Of course, investing in stocks always involves risks, and it’s essential to conduct thorough research and consider both the potential rewards and risks before making investment decisions.”
After seeing this compelling response from ChatGPT, we examined a number of promising 3D printing stocks and discovered 3DX Industries, Inc. (DDDX: OTC) that stood out from the pack far enough that we now work with them to help tell their story to investors interested in the 3D printing space.
We were looking for a company that offers the following criteria:
Proven and experienced management
Advanced printers in well-equipped factory with potential for large sales
Previously provided products for big name entities that would welcome future whale-sized orders when the company is ready to deliver
Early sales with potential for exponential growth
Small market cap and small number of outstanding shares
Under followed and undervalued.
After reviewing over a dozen 3D printing companies, 3DX Industries, Inc. stood out because it met all of our target criteria and with the promise for impressive growth in the relatively near future.  We believe shares are underfollowed and undervalued.
Following is a list as of September 12, 2024, of several competing and excellent investment candidates in the 3D printing sector, however, 3DX Industries emerges as our top choice for percentage growth after reviewing the industry:
NNDM – Nano Dimension - $2.15 per share - $471 million market cap
SYSS – Stratasys - $6.77 per share - $481 million market cap
XMTR – Xometry - $17.32 per share - $853 million market cap
DDD – 3D Systems - $2.19 per share -$292 million market cap
PTC – PTC - $167.80 per share - $20.3 billion market cap
DASTY – Dassault Systemes - $39.56 per share - $51.7 billion
PRLB – Proto Labs - $29.18 per share - $733.8 million market cap
MTLS – Materialise - $5.05 per share - $298 million market cap
DM – Desktop Metal - $4.48 per share - $149 million market cap
MKFG – Market Forged - $.1961 per share - $39.8 million market cap
VLD – Velo3D - $1.28 per share - $11 million marker cap
ONVO – Organovo - $.55 per share - $8.4 million market cap
Why 3DX?
To assure accurate information, we point to the current Investor Presentation Deck for 3DX.  Following are slides from that deck that describe the business, their technology, their clients, the market for 3D printing, and the growth potential for 3DX Industries.  Each slide tells a very important story in a succinct manner.

[AveragePenny]

“2024 Penny Stocks to Watch: ADHC, BTTC, RJDG, VHAI, CBDW Poised for Major Growth”

https://thestreetreports.com/2024-penny-stocks-to-watch-adhc-bttc-rjdg-vhai-cbdw-poised-for-major-growth/

These five companies Under five cents are driving innovation and growth across diverse sectors, positioning themselves for substantial shareholder value and long-term success.

Correction: On Wednesday September 11, 2024, it was reported American Diversified Holdings Corporation (OTC: ADHC) has acquired GlucoGuard which was incorrect. It should have been reported as follows: American Diversified Holdings Corporation (OTC: ADHC) is acquiring GlucoGuard, an AI-driven device for managing nocturnal hypoglycemia in diabetic patients. Developed by Zachary Smith, the device offers non-invasive glucose monitoring and delivery. Smith will join ADHC as a Scientific Advisor, positioning GlucoGuard to tap into the $28 billion U.S. diabetes market.

Bitech Technologies Corporation (OTCQB: BTTC) is a prominent independent power provider specializing in Battery Energy Storage Systems (BESS) to stabilize the grid and create sustainable revenue streams. The company’s expertise in renewable energy and smart energy solutions, including microgrids and Energy Management Systems (EMS), is supported by a skilled team with a strong industry impact. With a strategic portfolio of 1.965 GW in BESS projects and 1.4 GW in solar, Bitech is focusing on its BESS business, projecting significant growth as U.S. energy demand rises. Technological innovation, financial strength, and key partnerships position the company for rapid expansion in the clean energy sector.

RJD Green Inc.’s (OTC: RJDG) Silex Holdings Division has appointed Mark Gould as the new Division Manager. Gould brings a strong background in sales, marketing, and management within the construction products sector, having led a wholesale company that grew ten-fold during his six-year tenure. Under his leadership, the division will enhance offerings like cabinetry, doors, wood flooring, fireplaces, and hardware. CEO Ron Brewer expressed confidence in Gould’s ability to drive growth and add new revenue streams for Silex.

Vocodia Holdings Corp. (OTC: VHAI), an AI software company specializing in practical AI solutions, has provided an update on its progress and strategic path forward. The company has significantly reduced its cash burn rate from over $1 million to less than $300,000, improving financial health and operational efficiency. Vocodia is converting pilot programs into long-term contracts, validating its DISA technology platform, which enhances customer service solutions.

1606 Corp. (OTC: CBDW) plans to acquire a strategic stake in Adnexus, a leader in AI-driven drug discovery and infectious disease research, enhancing its presence in AI-powered healthcare solutions. This partnership is set to accelerate innovation, particularly in developing treatments for diseases like HIV and SARS-CoV-2 using advanced AI technology. With the global AI market projected to reach $2.25 trillion by 2030, this collaboration positions 1606 Corp. to capitalize on the rapid growth in AI and healthcare, driving shareholder value and establishing both companies as pioneers in their respective fields.

With cutting-edge advancements across diverse industries, these companies are setting new standards for innovation and growth. As they strengthen their market positions and expand their technological capabilities, American Diversified Holdings Corporation (OTC: ADHC), Bitech Technologies (OTCQB: BTTC), RJD Green Inc. (OTC: RJDG), Vocodia Holdings Corp. (OTC: VHAI) and 1606 Corp. (OTC: CBDW) are poised to deliver shareholder value and drive long-term success in their respective sectors.

[AveragePenny]

Peraso Inc. (NASDAQ: PRSO) Technology, Paradigm Shift, Breakthroughs, Expansion, Key Developments, Financial Outlook – Watch Now!

https://thestreetreports.com/peraso-inc-nasdaq-prso-technology-paradigm-shift-breakthroughs-expansion-key-developments-financial-outlook-watch-now/

Key Developments in July

Peraso Inc. (NASDAQ: PRSO), a global leader in mmWave technology for 60 GHz unlicensed and 5G licensed networks, announced a significant breakthrough in July. Tachyon Networks decided to expand its antenna kits to enhance the TNA-303X 60 GHz terminal, powered by Peraso’s X720 chipsets and mmWave Perspectus modulus. These kits operate in the license-free 60 GHz band, addressing the rising demand for reliable broadband solutions. Tachyon’s products are key components of the growing WISPs (Wireless Internet Service Providers) market, connecting users to Wi-Fi via specific access points.

Sector Impact

Management believes they are creating a paradigm shift in the wireless industry, affecting multiple sectors including telecommunications, mobile devices, security systems, smart home technology, and industrial automation. Enhanced connectivity and performance in these areas will drive significant advancements and efficiencies across these diverse applications.

Insights from Leadership

CEO Ron Glibbery and CFO Jim Sullivan recently discussed Peraso’s progress in an Alpha Wolf interview. They highlighted Peraso’s advancements in wireless technology and the company’s major customer, Ubiquity, a leading OEM. The CEO emphasized the anticipated continued demand for Peraso’s technology from service providers utilizing Ubiquity products. Watch the entire interview now!

Stock Performance and Market Analysis

On July 29, Zacks released a research report highlighting Peraso’s strong stock momentum, noting a 9.3% gain over 12 weeks and a beta of 1.82. The report also pointed out the stock’s attractive valuation, with a price-to-sales ratio of only 0.36, indicating a bargain for investors. Read entire news article now!

Financial Results Announcement

Peraso will announce its fiscal second-quarter financial results on August 12, 2024, after market close. A conference call will follow at 1:30 PM Pacific Time, available live on the Peraso corporate website.

Other Companies in these sector(s) to watch now:

Here are four public companies under $10 in the mentioned sectors showing strong market trends and awareness: Inseego Corp. (NASDAQ: INSG), Sonim Technologies Inc. (NASDAQ: SONM), A10 Networks, Inc. (NYSE: ATEN), iRobot Corporation (NASDAQ: IRBT). These companies are actively involved in their respective sectors, demonstrating market trends and awareness through their innovative products and services.

[AveragePenny]

Monkey Rock Group Inc. (OTC: MKRO) Expands Global Presence with Strategic Acquisitions


https://thestreetreports.com/monkey-rock-group-inc-otc-mkro-expands-global-presence-with-strategic-acquisitions/

Monkey Rock Group Inc. (OTC: MKRO), a US-based corporation, announces the acquisition of FGL GLOBAL LOGISTICA LTDA and C-FREIGHT AGENCIAMENTOS INTERNACIONAIS LTDA. These strategic acquisitions, finalized on July 22, 2024, through its subsidiary Global United Logistic and managed by Sviluppo Dati S.r.l., are set to boost Monkey Rock’s global presence and business strategy, generating combined annual revenues exceeding €56 million.

The newly acquired companies generate a combined revenue of approximately €56 million with an EBITDA margin of 34.1%, substantially boosting Monkey Rock’s financial performance and market position.

Monkey Rock aims to enhance production processes by integrating digitalization across all operations, leveraging Sviluppo Dati’s expertise. Additionally, the company is committed to ecological transition, focusing on transforming traditional logistics and transportation into green, zero-emission solutions, aligning with global sustainability goals.

Giuseppe Esposito, President of Monkey Rock Group, stated, “We are pleased to announce these strategic acquisitions. They underscore our commitment to growth and global presence, demonstrating MKRO’s readiness to establish its independent identity while driving innovation and sustainability in the logistics sector.”

Monkey Rock Group Inc. (OTC: MKRO), a company based in Italy within the European Union. It operates in the overnight and general freight shipping sector, competing with industry giants like FedEx Corporation (NYSE: FDX), United Parcel Service (NYSE: UPS), Alibaba Group Holding Limited (NYSE: BABA), Amazon.com, Inc. (NASDAQ: AMZN), CSX Corporation (NASDAQ: CSX), Union Pacific Corporation (NYSE: UNP), among others. Monkey Rock’s workforce has over 1900 employees, overseeing 70 plants. Notably, the company achieved annual consolidated revenues amounting to $285 million, Read more.

[AveragePenny]

$BSEG Big Screen Entertainment Group: Revolutionizing Film Production with AI

Article Link: https://richardacavalli.wixsite.com/greenplanetmicrocaps/about-1-1

Our treasure chest is filled with inspiring young companies that have innovative solutions to address a clean, low-carbon environment and to provide disruptive technologies to make life better

3 Cent BSEG Using AI to Create Moderate Budget Movies with Potential Blockbuster Revenues

Harnessing the Power of AI:

AI-Driven Content Creation: Big Screen Entertainment Group is leading the way in utilizing AI to create moderate budget films with mass appeal, leveraging AI projections to boost sales and profits.

Script to Sales Analysis: Our cutting-edge AI technology analyzes every aspect of a film or TV project, from script development to sales forecasts, ensuring high ROI potential.

Audience Engagement Predictions: AI predicts audience engagement and success, even for indie films, helping prioritize projects with the highest revenue potential.

Cost and Time Efficiency: AI accelerates and reduces the cost of development and production without compromising creative instincts, aiding informed decision-making throughout the process.

Optimized Distribution Strategies: AI establishes patterns based on previous releases to optimize distribution strategies, increasing revenue and sales for investors and productions.

Content Analysis and Financial Forecasts: Our platform offers comprehensive content analysis, financial forecasting, character & casting analysis, and packaging tools, enhancing the creative process while ensuring the human touch remains the final determinant.

[AveragePenny]

5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK


https://www.marketscreener.com/quote/stock/LONGEVERON-INC-118907392/news/5-Stocks-in-the-News-to-Watch-Now-LGVN-PRSO-SIRI-INBS-VTAK-47432541/

Longeveron Inc. (NASDAQ: LGVN) announced in July 2024 that the FDA granted Fast Track designation for its cellular therapy, Lomecel-B(TM), aimed at treating mild Alzheimer's Disease, accelerating its clinical development. The therapy also received RMAT designation, and the company announced a $9 million registered direct offering managed by H.C. Wainwright & Co.

Peraso Inc. (NASDAQ: PRSO) a leader in mmWave technology for 5G and 60 GHz networks, announced preliminary Q2 revenues of approximately $4.2 million, ending June 30, 2024, exceeding prior guidance. This represents a 50% sequential and 70% year-on-year growth. The stock has been trending upward, with investors anticipating it may rise above the 200 DMA and potentially challenge its three-month high of $2.04.

SiriusXM (NASDAQ: SIRI) reported year-on-year revenues at $2.16 billion, beating analysts' forecasts by 1.4%. The stock has surged from a multiyear low in the past month, likely due to a short squeeze ahead of its anticipated merger with Liberty Sirius XM Holdings, Read more.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced in July 2024, 3 new UK major manufacturers, have adopted its "Fingerprint Drug Screening System" for fast, reliable drug detection from fingertip sweat. Additionally, the system's successful biocompatibility testing advances it toward FDA 510(k) clearance, aiming for US market entry in 2025.

Catheter Precision (NYSE American: VTAK) implemented a new share structure on July 15, 2024, ensuring equal impact on shareholders. The company received evaluations and orders for its LockeT product from institutions such as UCLA Ronald Reagan Medical Center and HCA Healthcare. Their expansion strategy involves first introducing LockeT products to establish credibility, followed by the rollout of VIVO products. Additionally, the patient follow-up phase for the VIVO European Registry concluded in June 2023.

[AveragePenny]

Catheter Precision Inc. (NYSE American: VTAK) Moves Forward with Aggressive Expansion Strategy and New Share Structure

https://thestreetreports.com/catheter-precision-inc-nyse-american-vtak-moves-forward-with-aggressive-expansion-strategy-and-new-share-structure/

Catheter Precision Inc. (NYSE American: VTAK) is pushing forward with an aggressive expansion strategy, recently reflected in the acceptance of its new share structure by the capital markets. The company implemented a 1-for-10 reverse stock split of its common stock on July 15, 2024. This restructuring ensures all shareholders are equally affected without altering their ownership percentages.

Product Evaluations and Purchase Orders

As part of its expansion plan, Catheter Precision announced product evaluations and received purchase orders for its innovative LockeT product from prominent healthcare institutions, including UCLA Ronald Reagan Medical Center, Eisenhower Medical Center in California, Rady’s Children’s Hospital, and HCA Healthcare (NYSE: HCA). HCA Healthcare, a significant player in the healthcare industry, generated $64 billion in revenue in 2023.

Strategic Expansion Plan

Catheter Precision’s strategic expansion plan involves a two-step approach:

Introduction of LockeT Products: The company aims to first introduce its LockeT products into renowned healthcare institutions. This initial focus on leading medical centers is designed to establish a solid foundation and build credibility within the healthcare community. The innovative design and efficacy of the LockeT products serve as the entry point for Catheter Precision into these prestigious institutions.
Rollout of VIVO Products: Once the LockeT products are well-established and have gained the trust and acceptance of healthcare professionals, Catheter Precision plans to roll out its VIVO products. This phased approach ensures the company leverages the initial success of the LockeT products to facilitate the adoption of VIVO products, which may require a more significant integration effort due to their advanced technology and application.
By following this two-step strategy, Catheter Precision aims to create a seamless transition and adoption process for its innovative medical devices. The ultimate goal is to enhance patient care and outcomes by providing healthcare institutions with a comprehensive suite of cutting-edge products that address various medical needs. This strategic expansion not only strengthens Catheter Precision’s market position but also underscores its commitment to advancing medical technology and improving healthcare delivery.

Strengthening the Sales Team

To support its expansion efforts, Catheter Precision has made significant changes to its sales team. The company appointed Marie-Claude Jacques as the new Chief Commercial Officer, emphasizing boosting the sales of both LockeT and VIVO products. This move is part of a broader effort to expand the business development team and drive growth in the competitive medical device market.

Strengthening the Sales Team

To support its expansion efforts, Catheter Precision has made significant changes to its sales team by appointing Marie-Claude Jacques as the new Chief Commercial Officer. She, along with the newly joined sales team, previously drove Baylis Medical’s sales from approximately $10 million to $100 million before its acquisition by Boston Scientific Corporation (NYSE: BSX) for $1.75 billion. Read entire release. This strategic move aims to boost sales of LockeT and VIVO products and is part of a broader initiative to expand the business development team and drive growth in the competitive medical device market.

Here are additional companies in the healthcare sector: Teladoc Health Inc. (NYSE: TDOC), Alphatec Holdings Inc. (NASDAQ: ATEC), Ocular Therapeutix Inc. (NASDAQ: OCUL), and Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) offering diverse opportunities across healthcare, pharmaceuticals, and diagnostics, making them attractive options for investors interested in the healthcare sector.

[AveragePenny]

Peraso Inc. (NASDAQ: PRSO) Upward Stock Trend Amid Strong Q2 Revenue Projections and Recent Milestones

https://thestreetreports.com/peraso-inc-nasdaq-prso-sees-upward-stock-trend-amid-strong-q2-revenue-projections-and-recent-milestones/

Peraso Inc. (NASDAQ: PRSO), a global leader in mmWave technology for 5G licensed and 60 GHz unlicensed networks, has seen its stock trend upward recently. On July 16, the company announced preliminary revenues of approximately $4.2 million for the second fiscal quarter ending June 30, 2024, surpassing the previous guidance of $3.7 million to $4 million. This reflects a sequential growth of 50% and a year-on-year growth of 70%, driven by strategic developments and product innovations.

On Tuesday, July 16, 2024, Peraso Inc. (NASDAQ: PRSO), a global leader in mmWave technology for 5G licensed and 60 GHz unlicensed networks, saw its stock close slightly down, despite trading at 7.22 times its normal volume. The stock ended the day at $1.53, just below its 200-day moving average (DMA) of $1.56.

Investors are closely watching Peraso’s stock performance, anticipating a trendline that could rise above the 200 DMA. Such a movement could bring the stock back into breakout territory, potentially challenging its three-month high of $2.04.

Peraso’s stock activity comes amid a backdrop of significant company developments, including strong second-quarter revenue projections and strategic product innovations. The market is keenly aware of Peraso’s potential for growth and stability, given its recent performance and advancements in mmWave technology. As the company continues to leverage its technological edge and expand its market presence, investors remain optimistic about its future prospects.

In April, Peraso revealed that its X710 chip has been incorporated by Panasonic Corporation (Tokyo: 6752.T) (OTC: PCRFF) into system networks throughout Japan for its 60 GHz WLAN solution. This product features Peraso’s phased array antenna technology, delivering low latency and high-speed communication over distances similar to wired LANs, thus boosting its market attractiveness.

Additionally, in the second quarter, Peraso received a significant purchase order of $2.88 million in April, representing incremental last-time buys related to the company’s previous end-of-life (EOL) programs for its memory integrated circuit products. Up to that point, Peraso had booked EOL purchase orders totaling around $16.9 million, though the majority remained in backlog.

The company’s strong performance continued from the first fiscal quarter, where it generated total net revenues of $2.8 million, up from $1.8 million in the previous quarter. Product revenues for the quarter stood at $2.7 million, compared to $1.5 million in the prior quarter.

These developments highlight Peraso’s strategic growth and technological advancements, solidifying its position as a leader in the mmWave technology sector and attracting significant investor attention.

Here are additional companies in the technology semiconductor and communications equipment sectors: United Microelectronics (NYSE: UMC), AXT, Inc. (NASDAQ: AXTI), Valens Semiconductor Ltd. (NYSE: VLN), and Getty Images Holdings, Inc. (NYSE: GETY). These companies offer diverse opportunities and present attractive options for investors interested in this industry and its sectors.

[AveragePenny]

$LVVV HEMP-DERIVED THC PRODUCTS ARE ON A FAST RISE

https://stockwatchindex.com/hemp-derived-thc-products-are-on-a-fast-rise/

Hemp-derived THC products are on a blindingly fast rise. These Hemp products, including oils, edibles, topicals, and even canned drinks, are derived from hemp plants that contain less than 0.3% THC, the psychoactive compound found in marijuana. These products offer many of the same therapeutic benefits as marijuana, such as pain relief, stress reduction, and improved sleep, but without the “HIGH” associated with traditional cannabis products.

One of the most significant advantages of hemp-derived THC products is their legal status. While marijuana remains illegal under Federal law in the United States, hemp-derived products are legal under the 2018 Farm Bill. This means that producers can ship the product across state lines, and consumers can purchase hemp-derived THC products online or in stores without restrictions or fear of legal repercussions, making them easier and more widely accessible to consumers than traditional cannabis products.
In addition, hemp-derived THC products are often cheaper than their marijuana counterparts, as hemp plants are generally significantly less expensive to cultivate and process. This lower cost could make hemp-derived products more appealing and competitive to consumers, especially those who are looking for affordable alternatives to traditional cannabis products.
Naturally, this poses a significant threat to the producers in the regulated marijuana market and the traditional cannabis distribution and dispensary model, as dispensaries may struggle to compete with the convenience and affordability of hemp-derived products. As more states and countries legalize marijuana for both medical and recreational use, the market for cannabis products has been booming. However, the broad introduction and availability of hemp-derived THC products have the potential to disrupt this market in a significant way. As more consumers turn to these products for their therapeutic benefits, the traditional cannabis industry may need to evolve to remain competitive in an increasingly crowded market.
Additionally, the increasing popularity of hemp-derived THC products could also lead to a decrease in demand for marijuana, potentially impacting the revenues of cannabis dispensaries and the overall profitability of the regulated marijuana market. This could force dispensaries to adapt their business models or face the possibility of closure.
Traditional cannabis companies, producers, distributors, and retailers should be prepared for this new wave (a wave that has been slowly growing larger for some time) if they want to compete with this only loosely regulated Hemp market. There will always be the “hardcore” group of devoted cannabis-only producers and consumers. Still, others might be happy to get similar results to what they are seeking, with less expensive products and easier access. There is a place for both. Good management teams should embrace the opportunity to combine both markets; after all, it is all the same (nearly the same) plant family and cultivation process.
One of the companies we have been covering in our research, Livewire Ergogenics, Inc. (OTC: LVVV), manages a large producer of traditional sun-grown cannabis products in California. The company has been exploring this opportunity for some time and is close to launching its first entry into this market. For more information about LiveWire Ergogenics, visit www.livewireergogenics.com or at X at @livewireLVVV.

[AveragePenny]

Trump Media (NASDAQ: DJT) Soaring in Pre-Market After Assassination Attempt; Bullish Sentiment on Small Caps: PRSO, VTAK, DYAI, INBS


https://thestreetreports.com/trump-media-nasdaq-djt-soaring-in-pre-market-after-assassination-attempt-bullish-sentiment-on-small-caps-prso-vtak-dyai-inbs/

July 15, 2024 – In an unprecedented surge, Trump Media & Technology Group (NASDAQ: DJT) saw its stock price skyrocket in pre-market trading today, following news of an assassination attempt on former President Donald Trump. The attempted attack, which occurred late last night, has not only brought a wave of sympathy but also renewed investor interest in Trump-associated enterprises.

The former President, who is also a key figure in the company, survived the attempt unharmed. Sources close to the situation indicate that the incident has galvanized his support base and investors alike, pushing DJT shares up by over 25% in the early hours of trading.

Bullish Sentiment on Small Caps

The heightened market activity surrounding DJT has also cast a bullish light on several small-cap stocks. Among the noteworthy mentions are:

Catheter Precision Inc. (NYSE American: VTAK): Specializing in innovative medical devices, Catheter Precision is gaining traction as it reports positive clinical data and expands its intellectual property portfolio. The market is bullish on VTAK, anticipating strong revenue growth driven by its advanced healthcare solutions expansion strategy following a new stock structure (1 for 10 stock split) which begins today.
Peraso Inc. (NASDAQ: PRSO): Known for its cutting-edge mmWave technology, Peraso Inc. is attracting attention due to its recent technological advancements and ISO 9001:2015 certification. Investors are optimistic about the company’s future, predicting significant growth in the semiconductor sector. Ladenburg Thalmann initiates coverage.
Dyadic International Inc. (NASDAQ: DYAI): With a focus on synthetic biology and biopharmaceutical applications, Dyadic International has been a consistent performer. The company’s recent strides in gene expression and enzyme production have bolstered investor confidence, making DYAI a small-cap to watch. Zacks SmallCap valued Dyadic at $9 a share in a July 1 report, read entire report now and See HC Wainwright & Co Buy Recommendation.
Intelligent Bio Solutions Inc. (NASDAQ: INBS): This biotech firm, known for its groundbreaking work in diagnostics and bioinformatics, has seen a renewed increased in investor interest. INBS’s innovative solutions in personalized medicine are driving its stock upwards as the company continues to make headway in the biotech industry.
Market Dynamics

The assassination attempt on Donald Trump has not only impacted Trump Media but has also created a ripple effect across the stock market, particularly benefiting these small-cap stocks. Analysts suggest that the heightened media coverage and public attention could sustain this bullish trend, at least in the short term.

Investors are advised to keep a close watch on these developments as the market reacts to the unfolding events. The interplay between political events and market dynamics continues to present both opportunities and risks, underscoring the importance of informed investment decision

[AveragePenny]

Stocks to Watch: Hidden Opportunities Under 10 Cents, Huge Growth Potential: $RJDG, $PRST, $VHAI, $SLNA, $MKRO

https://thestreetreports.com/stocks-to-watch-hidden-opportunities-under-10-cents-huge-growth-potential-rjdg-prst-vhai-slna-mkro/

Investors may uncover certain stocks by conducting more thorough research, and this feature aims to highlight some potential opportunities. It will examine five (5) stocks trading under 10 cents per share that could be worth tracking at this time.

RJD Green Inc. (OTC: RJDG), a publicly traded holding company focused on asset acquisition and management, announced its financial results for the third fiscal quarter ending May 31, 2024, on July 15. The company reported revenues of $4,400,770, a net operating profit of $1,078,388, and cash and cash equivalents of $2,054,962. RJD Green is on track to surpass $6 million in annual revenues. Last month, the company revealed that its Silex Holdings division secured the rights for the distribution, sales, and installation of a new product line set to launch in August 2024.

Presto Automation Inc. (NASDAQ: PRST), a leading drive-through AI and automation technology provider for the restaurant industry, is a company to watch. In May, Presto Automation announced its financial results for the third quarter ending March 31, 2024. The company reported revenues of $4.5 million but incurred a net loss of $18.1 million, with an adjusted EBITDA loss of $12.2 million for the quarter. On May 20, Presto Automation secured $3 million in new financing through common equity and subordinated debt, with contributions from several parties, including existing investor Remus Capital.

Vocodia Holdings Corp. (NASDAQ: VHAI), a leader in AI software development focused on practical AI applications, announced on June 24 that CBOE BZX Exchange Inc. issued a Staff Delisting Determination (SDD). The SDD, dated June 14, 2024, pertains to the company’s warrants and common shares. It was noted that Vocodia Holdings’ common stock fell below the exchange’s minimum bid price requirement of $1 on March 19 and has since remained non-compliant. In response, the company has requested an oral hearing before a CBOE Hearings Panel.

Selina Hospitality Inc. (NASDAQ: SLNA), a global lifestyle and hospitality company catering to Gen Z and millennial travelers, announced in May that it received a notice from The NASDAQ Capital Market LLC. According to the news release, the notice stated that the company was delinquent in filing its Form 20-F for the year ended December 31, 2023, as required by the exchange’s listing standards. Selina Hospitality Inc. was given a deadline of September 3, 2024, to regain compliance.

Monkey Rock Group Inc. (OTC: MKRO), a U.S.-based entity incorporated in Delaware, announced on July 15 the initiation of its acquisition process for merging with Italian company Sviluppo Dati SRL. According to the press release, Monkey Rock Group highlighted Sviluppo’s specialization in payroll processing and accounting services for logistics companies. The firm signed an agreement with Sviluppo on July 7, 2024, to acquire a 50% stake. This agreement also grants Monkey Rock Group control over Global United Logistic Iberia and Global United Logistic, both Sviluppo subsidiaries. Monkey Rock Group aims to enhance production processes through digitization by utilizing Sviluppo’s expertise.

[Zardiw]

$PACB +67% #DDAmanda Video Analysis - #1 Stock Scanner/Screener

Z

[AveragePenny]

Penny Stocks to Watch in July 2024: SPZI, HYSR, BIEI, SMCE, HALB, BMXC


https://www.marketscreener.com/quote/stock/WALMART-INC-4841/news/Penny-Stocks-to-Watch-in-July-2024-SPZI-HYSR-BIEI-SMCE-HALB-BMXC-47362221/

Bemax, Inc. (OTC: BMXC) is dynamically exploring growth avenues in the booming global consumer staples and household products sectors. Bemax specializes in marketing and distributing household goods from companies poised to influence the consumer staples market. Bemax's Mother's Touch® disposable diapers are available through Walmart Inc. (NYSE: WMT).

Bemax, Inc. (OTC: BMXC) exports private-label household items to emerging markets globally. The company announced it will accept pre-orders for its enhanced Mother's Touch® disposable diapers starting August 2024 on www.walmart.com. This development aligns with Bemax's commitment to exceeding customer expectations. The new diapers feature a non-woven top sheet, 3D leak guard, peal-patterned spunbond, and a 3-liner wetness indicator, emphasizing superior quality.

Bemax, Inc. (OTC: BMXC) has a 52-week high of $0.0595. Investors should watch this stock due to its expanding presence in the global consumer staples and household products sectors, innovative product offerings like the improved Mother's Touch® disposable diapers, and its strategic partnerships, including distribution through Walmart Inc. (NYSE: WMT). These factors position Bemax for potential growth and increased market influence.

Mother's Touch® disposable diapers among other products will be available through its extensive distribution network to ensure greater accessibility and adaptability. While customers have generally approved of the Mother's Nature-branded products, Bemax recognized the need for an improved offering to meet evolving customer demands. The enhanced product aims to strengthen the bond between mothers and their babies, leading to its launch.

Other stocks trading at a penny to Watch JP 3E Holdings, Inc./SPOOZ, Inc. (OTC: SPZI), SunHydrogen Inc (OTCQB: HYSR), Premier Graphene, Inc. (OTC: BIEI), SMC Entertainment Inc (OTC: SMCE), Halberd Corporation (OTC: HALB)

[AveragePenny]

SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL


https://thestreetreports.com/10-smallcap-tech-biotech-stocks-july-aug-2024-zvsa-dyai-zvra-prso-rlmd-vtak-ento-inbs-kavl/

Investors seeking promising opportunities in the biotech and tech sectors should keep an eye on several companies showing potential for significant market turnarounds. Recent upticks in stock prices suggest these companies could be on the cusp of substantial growth. Here’s a closer look at some of these emerging players:

ZyVersa Therapeutics’ (NASDAQ: ZVSA) innovative approaches to kidney and inflammatory diseases, along with successful funding rounds, are boosting its stock price and investor interest.

Dyadic International Inc. (NASDAQ: DYAI) Its innovative C1 gene expression platform and recent achievements in vaccine and therapeutic protein production, Dyadic has garnered significant attention in the biopharmaceutical sector. Zacks SmallCap valued Dyadic at $9 a share in a July 1 report, read entire report now and See HC Wainwright & Co Buy Recommendation.

Zevra Therapeutics (NASDAQ: ZVRA) Zevra’s robust pipeline in cancer treatments and strategic partnerships are driving substantial investor interest and stock momentum.

Peraso Inc. (NASDAQ: PRSO) As a leader in mmWave technology and wireless communication solutions, Peraso’s recent certification and technological advancements have increased market confidence. Ladenburg Thalmann, a renowned Wall Street firm since 1876, initiated coverage.

Relmada Therapeutics (NASDAQ: RLMD) Positive trial data and regulatory progress for its treatments for depression and other central nervous system disorders, Relmada is capturing significant market confidence.

Catheter Precision Inc. (NYSEAMERICAN: VTAK) Known for its cutting-edge medical devices for cardiac procedures, Catheter Precision’s latest product launches and clinical success stories have attracted investors.

Entero Therapeutics’ (NASDAQ: ENTO) advancements in gastrointestinal therapies and promising clinical trial developments have sparked investor optimism.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Leading advancements in bioanalytical solutions and personalized medicine, Intelligent Bio Solutions’ recent technological breakthroughs and strategic collaborations have positioned it strongly in the market.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Carving out a niche in the nicotine delivery industry, Kaival Brands’ strong sales growth and market expansion are driving investor interest.

These companies represent exciting investment opportunities, each with its unique strengths and recent positive developments. As they continue to innovate and achieve milestones, their stocks are beginning to reflect their potential for significant market turnarounds. Investors looking for high-growth prospects may find these stocks worth watching.

[AveragePenny]

$UCLE U.S. Nuclear Corp. is First to $7.4B PFAS Detection Market

https://richardacavalli.wixsite.com/greenplanetmicrocaps/ucle-surprises-first-to-pfas-market

The EPA recently passed regulations that will require 148,000 water providers to test and treat their water for PFAS which is believed to be responsible for widespread cancers, birth defects, high cholesterol and more.

Currently, there are no devices available for sale for this testing and all water providers must send in samples to the big labs with high costs and long times for results that can take several weeks.

The new regulations create what is projected to be a $7.4B need for portable and accurate, and fast PFAS detection devices in the United States and probably double that for the rest of the world.

U.S. Nuclear Corp., a long-standing company known for its’ expertise in radiation measurement recently announced their new portable PFAS detection and monitoring device that meets government requirements.

Each unit sells for about $50,000 and demand from 148,000 municipal water districts and industrial manufacturers is projected to be $7.4B for the United States alone

U.S. Nuclear Corp trades at 8 cents per share with a very small market cap of about $3.15 million.



The EPA has taken strong action designating two widely used PFAS as hazardous substances under the Superfund law, improving transparency and accountability to clean up PFAS contamination in communities. The U.S. Environmental Protection Agency (EPA) is taking another step in its efforts to protect people from the health risks posed by exposure to “forever chemicals” in communities across the country.

?

Almost a year ago, US Nuclear Corp. (UCLE: OTCQB) revealed in a press release that they were offering portable and benchtop PFAS detection devices that are capable of determining extremely minute amounts of PFAS, PFOS and PFOA’s down to 1 part per trillion within less than 2 minutes. The units are expected to be sold for $50,000 per unit and there are now about 148,000 municipal water districts that will be required to test their water within a relatively short timeline.

?

Our research indicates that US Nuclear’s PFAS detection system is unique to the market.

?

Exposure to per-and polyfluoroalkyl substances (PFAS) has been linked to cancers, impacts to the liver and heart, and immune and developmental damage to infants and children. This final rule will designate two widely used PFAS chemicals, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), also known as Superfund, and will help ensure that polluters pay to clean up their contamination.

?

This final action will address PFOA and PFOS contamination by enabling detection and cleanup of these harmful chemicals and ensuring that leaks, spills, and other releases are reported. This action builds on the recently finalized standards to protect people and communities from PFAS contamination in drinking water and represents the latest step the Biden-Harris Administration is taking to protect public health and welfare and the environment under EPA’s PFAS Strategic Roadmap and to prevent cancer before it starts through the Biden Cancer Moonshot.

?

In addition to the final rule, EPA is issuing a separate CERCLA enforcement discretion policy that makes clear that EPA will focus enforcement on parties who significantly contributed to the release of PFAS chemicals into the environment, including parties that have manufactured PFAS or used PFAS in the manufacturing process, federal facilities, and other industrial parties.

?

Conclusion

US Nuclear Corp. is a unique long-standing company that got its start from the Manhattan Project, the development of the Atomic Bomb which the recent movie Oppenheimer was all about. Since then, US Nuclear Corp has developed a wide array of sensitive detection instruments for government and research lab use and is now branching out to broader markets with large unmet needs such as PFAS detectors that are capable of measuring PFAS in less than 4 parts per trillion which is like a grain of sand in an Olympic sized swimming pool.

?

US Nuclear also owns an interest and is partnered with the leading fusion energy and radioisotope developers, MIFTI and MIFTEC and an advanced materials company called Grapheton that is making breakthrough medical devices that can be implanted in the body that have greatly extended life spans and game changing advantages over the competition.

?

With strong and well-timed growth potential and a total market cap of about $3.15 million, and shares trading close to historic lows, US Nuclear Corp appears to be an outstanding investment consideration.

[AveragePenny]

Stocks Under 1¢: June 2024 Gains, July 2024 Watchlist: SMCE, SPZI, RSPI, HALB, BIEI, RJDG

https://thestreetreports.com/stocks-under-1%c2%a2-june-2024-gains-july-2024-watchlist-smce-spzi-rspi-halb-biei-rjdg/

A select group of stocks trading under one penny, initially highlighted in June 2024 and showing significant gains, are once again on our robust watchlist for July 2024, warranting immediate consideration.

SMC Entertainment, Inc. (OTC: SMCE): Achieved fully reporting status post-SEC review and acquired 100% of ChainTrade Ltd.’s assets, with stock gains over 700% in June 2024 and volume trending towards a 52-week high of $0.0079.

JP 3E Holdings, Inc. (OTC: SPZI): Advances with Bloxcross Inc. acquisition, innovating global bilateral trade and blockchain financial applications. Stock volume is heating up again, with a 52-week high of $0.0132.

Respirerx Pharmaceuticals Inc (OTC: RSPI): Following a $1.8 million DOD translational research award to Shirley Ryan AbilityLab, the stock value and trading volume have increased significantly, with momentum expected to continue towards a 52-week high of $0.0069.

Halberd Corp. (OTC: HALB): In cooperation with Athena GTX, poised for major advancements in military and global health solutions. The stock has been moving in a tight range recently with a 52-week high of $0.012.

Premier Graphene Inc. (OTC: BIEI): Announced acquisition of a third commercial industrial license in Mexico with HGI Industrial Technologies. Leveraging resources from the US and Mexico for graphene-based products, the stock has a 52-week high of $0.0017.

RJD Green Inc. (OTC: RJDG): Boosts market presence with new Silex Holdings product line launch and robust sales initiative targeting home builders, remodelers, DIY enthusiasts, and commercial contractors. Following a record revenue report in early June 2024, trading volume is expected to be more consistent in July, with a 52-week high of $0.0119.

[AveragePenny]

Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS

https://thestreetreports.com/roaring-kitty-expands-horizons-key-stocks-to-watch-as-influencer-shakes-up-market-chwy-dyai-woof-vtak-inbs/

The influencer ‘Roaring Kitty’ shook the stock markets with the ‘meme stock’ phenomenon, with GameStop, Inc. (NYSE: GME) becoming his most notable trade. Meme stocks have generated substantial wealth for traders, and it seems Roaring Kitty is now broadening his scope. This feature offers insight into the stock’s worth monitoring in light of Roaring Kitty’s latest moves.

Chewy Inc. (NASDAQ: CHWY): Chewy experienced significant volatility on July 1 after a regulatory filing revealed that Roaring Kitty acquired a 6.6% stake. Roaring Kitty bought 9 million shares of the pet retailer, totaling over $261 million at a closing price of $29.05 per share on June 28. This made him the third-largest shareholder, with the stock gaining over 20% before markets opened on July 1.

Dyadic International Inc. (NASDAQ: DYAI): Dyadic International, a leader in cell culture solutions, announced a strategic partnership with Proliant Health and Biologicals (PHB) last month. PHB will provide $1.5 million upfront for developing high-volume, cost-effective cell culture products set to enter the $6 billion serum albumin market in the first half of 2025. Zacks SmallCap valued Dyadic at $9 a share in a July 1 report. Read entire report now.

Petco Health and Wellness Company Inc. (NASDAQ: WOOF): Petco released its 2023 ESG report last month, highlighting its commitment to pet owners, pets, and employees. The Petco Love initiative found homes for 142,924 pets in the 2023 fiscal year and donated $33.5 million to 2,000 animal welfare organizations and shelters. Petco also expanded its in-store veterinary hospitals to over 280 locations.

Intelligent Bio Solutions Inc. (NASDAQ: INBS): Intelligent Bio Solutions is gaining attention with its expansion into the UK market. The company announced that its Intelligent Fingerprinting Drug Screening System would be adopted by three major British retailers, with a combined employee strength of 55,000. Additionally, two major UK warehouse and logistics customers, with over 70,000 locations and 15,000 employees combined, will implement the screening system. The company also commenced dosing for its FDA-supporting pharmacokinetic study, with results expected by the end of July, and successfully completed the in-clinic portion of its PK study for the 510(k) pathway for regulatory approval.

Catheter Precision Inc. (NYSEAMERICAN: VTAK): Catheter Precision saw its stock surge 43.58% on July 1, hitting an intraday high of $0.84 per share after announcing unaudited revenues for the fiscal quarter and six months ended June 30, 2024. The company reported sales of its innovative LockeT and VIVO products. The VIVO system, a non-invasive 3D imaging technology, enhances the efficiency of ventricular ablation, aligning with the company’s expansion strategy. Read Entire Update Now!

[AveragePenny]

$GRNF GRN Holding Corporation Announces Rebranding to Marijuana Inc. Under the Leadership of the “Henry Ford of the Marijuana Industry,” Donald Steinberg

https://www.globenewswire.com/news-release/2024/06/26/2904471/0/en/GRN-Holding-Corporation-Announces-Rebranding-to-Marijuana-Inc-Under-the-Leadership-of-the-Henry-Ford-of-the-Marijuana-Industry-Donald-Steinberg.html

ESTERO, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- via IBN -- GRN Holding Corporation, (OTC: GRNF) is proud to announce its strategic rebranding to Marijuana Inc. (www.marijuanainc.com) to signal a new era of growth and innovation in the global cannabis industry. This transformation is led by the renowned CEO, Donald Steinberg, whose illustrious career in the marijuana sector spans over five decades.

Donald Steinberg: Recognized as the "Henry Ford of the Marijuana Industry.”

Donald Steinberg, documented in multiple books for his pioneering efforts in the marijuana industry, has a storied history that sets him apart from all others in the field. In the 1980s, Steinberg was recognized by Centac, a U.S. government agency, as the largest importer of marijuana into the United States in the 1970s and the largest U.S. distributor. His unmatched ability to build and scale massive global organizations is showcased in his extensive experience and achievements, which continued in all avenues he has pursued as a disruptive entrepreneur.

A notable moment in his career was featured in an interview with American journalist and talk show host Charlie Rose, who highlighted his significant contributions and insights into the marijuana industry. A “teaser” excerpt of Steinberg’s interview with Rose can be viewed at the following link:

.

Being described as “The Henry Ford of the Marijuana Industry” and the “Inventor of the Marijuana Industry” by investigative journalist James Mills exemplifies the impact Steinberg has made on the marijuana industry. Nearly half of the U.S. now legalizes marijuana for recreational use with even more states decriminalizing marijuana or approving its use for medical purposes. Building this foundation was not without risk. Steinberg, like others, was punished for his highly successful efforts in bringing full freighters of marijuana directly into ports across America for distribution.

Since then, Steinberg has been quiet about his past and has worked to successfully build innovative and disruptive businesses unrelated to marijuana, showcasing his expertise as an honest and intelligent businessman in a multitude of areas. Today, for the first time, he is opening up about his trailblazing past in the marijuana industry of the United States, in order to propel Marijuana Inc. to the forefront of the global market.

Steinberg's Vision for Marijuana Inc.

In the 1990s, Steinberg co-founded One World Communications, one of the world’s largest affiliate marketing companies in the international telecom industry, boasting over 200,000 members across more than 30 countries. His visionary approach continued in 2008 when he co-founded Medical Marijuana Inc., the first company on a U.S. stock exchange dedicated to the marijuana industry.

“As many countries relax their laws on marijuana, I see an opportunity to be involved at the beginning of a new chapter in the marijuana industry. Moving ahead with this idea, I formed Marijuana Inc., took control of an existing public company and merged the two entities to pursue growth opportunities. The name change has been filed and we are awaiting final approval from OTC now,” said Steinberg.

Global Expansion with Legendary Seeds

During this time, Legendary Seeds, a Colombian company formed by Andres Perez and One World Legends, has been at the forefront of producing a wide variety of Landrace strains and well-known hybrids. One World Legends, led by Rocky Petrullo, has supplied Legendary Seeds with the genetics to produce these strains, including Panama Red, Acapulco Gold, Mowie Wowie, and many more. Gaining approval from the Colombian government to export started two years ago, and is now in the final stages, marking a significant milestone in the global marijuana market.

Conclusion

Under Steinberg’s leadership, Marijuana Inc. is poised to revolutionize the marijuana industry once again by leveraging his extensive experience, innovative vision, and strategic global partnerships. Stay tuned for further updates as Marijuana Inc. continues to make strides in becoming a leading global provider of premium cannabis products.

[AveragePenny]

July 2024 Hot Small-Cap Stocks Under $5 Gaining Now: KAVL, VTAK, INBS, BSFC, PRSO


https://www.benzinga.com/pressreleases/24/06/ab39546454/july-2024-hot-small-cap-stocks-under-5-gaining-now-kavl-vtak-inbs-bsfc-prso#StocksToWatch

[AveragePenny]

Peraso Inc. (NASDAQ: PRSO) Featured in “Microwave Journal,” Showcases 60 GHz mmWave Technology for Defense and Other Sectors

https://thestreetreports.com/peraso-inc-nasdaq-prso-featured-in-microwave-journal-showcases-60-ghz-mmwave-technology-for-defense-and-other-sectors/

Recently, Peraso Inc. (NASDAQ: PRSO), a leader in mmWave products, introduced a new wireless platform for secure tactical communications, featured in the “MicrowaveJournal.” This innovative platform leverages the company’s advanced mmWave product line, driving a paradigm shift in the wireless technology communications industry across multiple sectors.

In the news article, Peraso Inc. highlighted that their new platform opens opportunities to enter new markets by showcasing the benefits of 60 GHz mmWave technology in the defense sector. The platform supports low-latency, high-bandwidth applications using unlicensed mmWave spectrum, providing a high bandwidth connection rate exceeding 3 Gbps for its users. Read entire news article now.

Peraso Inc. (NASDAQ: PRSO) highlighted its new platform, leveraging 60 GHz mmWave technology, which opens opportunities in the defense sector. This platform supports low-latency, high-bandwidth applications using unlicensed mmWave spectrum, offering connection rates exceeding 3 Gbps.

Peraso Inc. (NASDAQ: PRSO), a leader in 60 GHz and 5G mmWave technology, reported impressive fiscal Q1 2024 financial results on May 13, with net revenue of $2.8 million, up from $1.8 million the previous quarter, exceeding Wall Street expectations. Their 60 GHz modules enable multi-gigabit data transfer rates crucial for military operations. The platform, powered by PRS1145 and PRS401 ICs forming the X720 chipset, offers lightweight, power-efficient solutions ideal for tactical applications. Peraso also provides modules, chipsets, IP, and software for immersive video, factory automation, and wireless access. Their technology is integrated into Panasonic Corporation’s (Tokyo: 6752.T) (OTC: PCRFF) systems across Japan.

Recently featured with Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE), Plug Power Inc. (NASDAQ: PLUG), and SunPower Corporation (NASDAQ: SPWR), Dyadic International Inc. (NASDAQ: DYAI). Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside! (thestreetreports.com)

[AveragePenny]

Catheter Precision Inc. (NYSE American: VTAK) Stock Volume Soars with Middle East Expansion of VIVO 3D Heart Imaging System

https://thestreetreports.com/catheter-precision-inc-nyse-american-vtak-stock-volume-soars-with-middle-east-expansion-of-vivo-3d-heart-imaging-system/

The United States-based medical device company Catheter Precision Inc. (NYSE American: VTAK) gained significant attention on June 20 after announcing its first purchase order from Qatar. In the news release, Catheter Precision revealed that an initial evaluation of its VIVO product was conducted earlier in 2024 at the Hamad Medical Corporation Heart Hospital in Doha.

Catheter Precision Inc. (NYSE American: VTAK) surged 5.28% on June 25, 2024, with trading volume hitting 3.09 times the norm hitting an intraday high of $0.7199. The stock climbed an additional 4% in after-hours trading and boasts a 28.9% increase since June 20, 2024. VTAK’s trading volumes have seen a notable uptick since June 11, 2024, positioning it in breakout territory, surpassing its 20, 50, and 200-day moving averages. With numerous bullish indicators consistently present, VTAK is an attractive buy during sideways market movements or on dips, as its strong trend is expected to continue this upward trajectory for a while.

Catheter Precision’s VIVO (View Into Ventricular Onset) is a revolutionary non-invasive 3D imaging system that helps physicians identify the origin of ventricular arrhythmias before heart procedures. VIVO streamlines ventricular ablation, saving time and reducing complications. The company, following its expansion strategy, had previously announced this innovation. The company is renowned for its two key innovative products: VIVO™, aiding in ventricular arrhythmia source detection pre-procedure, and LockeT, a closure retention device. Read Entire Update Now!

These innovative medical devices, develops cutting-edge products aimed at enhancing patient care for physicians and hospitals. By collaborating with medical professionals, Catheter Precision improves its groundbreaking technologies and existing products, making workflows more efficient and reducing heart procedure times and potential complications. Their product, which received marketing clearance from the U.S. FDA and CE mark approval for the European Union, exemplifies their commitment to elevating healthcare standards.

Featured by Barchart alongside GameStop Corp (NYSE: GME), AMC Entertainment (NYSE: AMC), Novavax (NASDAQ: NVAX), Peraso (NASDAQ: PRSO), Intelligent Bio Solutions Inc (NASDAQ: INBS), Dyadic International Inc. (NASDAQ: DYAI) see: https://www.barchart.com/story/news/26816026/gamestop-raises-214-billion-meme-stocks-buzz-fuels-gains-watch-gme-prso-dyai-vtak-amc

[AveragePenny]

RJD Green Inc. (OTC: RJDG) Launches New Product Line Following Record Revenue Financial Report

https://thestreetreports.com/rjd-green-inc-otc-rjdg-launches-new-product-line-following-record-revenue-financial-report/

On June 25, RJD Green Inc. (OTC: RJDG) announced that its division, Silex Holdings, secured distribution and installation rights for a new product line set to launch in August 2024. The news release highlighted Silex Holdings’ strategic focus on acquiring rights for products that align with its core operations, emphasizing synergy and market expansion.

The focus is on manufacturing products such as countertops and walls from materials like quartz, marble, granite, quartzite, and other stones. The company also announced a robust sales and marketing initiative to maximize Silex’s revenue and profit potential from these products.

It was noted that the Silex Holdings team enhanced opportunities by securing installation and sales rights for several new offerings. These include four cabinetry products: facets, hardware, flooring, commercial and residential doors, and tile. This comprehensive product collection enables RJD Green customers to make purchases seamlessly in a single process.

The products will be available to a wide range of customers, from home builders and remodelers to retail DIY enthusiasts and commercial contractors. This diverse customer base is expected to drive higher revenues and profits, leveraging Silex’s four-state focus to significantly boost its brand presence.

Recently highlighted alongside Crown Electrokinetics Corp. (NASDAQ: CRKN) prior to 1:150 stock split effective June 25, 2024, Presto Automation Inc. (NASDAQ: PRST), Selina Hospitality PLC (NASDAQ: SLNA), and Houston Natural Resources Corporation (OTC: HNRC), see: Investor Spotlight: Key Developments Boost Interest In – MarketScreener

[AveragePenny]

Major OTC Volume Buzzers: SPZI, DPUI, RJDG, GGSM, HNRC, RSPI, HALB, DKSC, BIEI


https://thestreetreports.com/major-otc-volume-buzzers-spzi-dpui-rjdg-ggsm-hnrc-rspi-halb-dksc-biei/

JP 3E Holdings, Inc. (OTC: SPZI): The stock has been moving within a narrow range over the past few trading sessions on high volume. Last month, the company reached an agreement to acquire a majority ownership interest in Bloxcross, Inc. Bloxcross is a trailblazing digital asset innovation company recognized for its groundbreaking platform that revolutionizes global bilateral trade, cross-border payments, and financial applications through advanced blockchain technologies.

Discount Print USA (OTC: DPUI) stock has been soaring over the past week and surged another 54.55% on Tuesday to close at $0.0017. The stock has gained almost 143% in the past week. Discount Print USA, Inc., a commercial printing management company, provides low-priced printing services to businesses and individuals.

Rjd Green Inc. (OTC:RJDG) has been gaining momentum over the past week, up by about 6%. In May, Silex Holdings Inc. posted revenue of $865,730 with a NOP of $242,404. Moreover, the company expects that revenues will continue to surpass 2023 through the remainder of 2024.

Gold and GemStone Mining Inc. (OTC: GGSM) continued to trend higher on Tuesday and jumped 27%, extending its weekly gains to 65%. Gold and GemStone Mining Inc. specializes in acquiring, exploring, and developing gold and silver properties across North and South America.

Houston Natural Resources Corporation (OTC:HNRC) stock gas gained momentum over the past week with a jump of 9.68%. In Q1, the company reported revenues of $4,292,940, a jump of 2.7% year-over-year. In the same period, the company recorded earnings of $2,736,961, which reflected a year-on-year rise of 2.8% from the earnings of $2660713 in the prior-year period. The company recorded a net asset value (NAV) of $0.27 per share.

Respirerx Pharmaceuticals Inc (OTC: RSPI) stock soared over 31% in the past week on increased volume. Last month, the company announced that the Department of Defense (DOD) had approved a $1.8 million translational research award to Shirley Ryan AbilityLab.

Halberd Corp. (OTC:HALB) stock has been moving in a tight range over the past few sessions. On Tuesday, the stock went up 5.67%. The company, in cooperation with Athena GTX, is standing at the threshold of some major advancements to treat the issues facing not only our military but people around the world.

Dakshidin (OTC:DKSC) stock has moved up 17% over the past week on increased volume. Moreover, the stock has seen unusual volume over the past week, with more than 110 million shares traded hands on Tuesday.

Premier Graphene Inc. (OTC:BIEI) announced on May 13 its acquisition of the third commercial industrial license in Mexico in partnership with HGI Industrial Technologies. The company stated that it is leveraging resources from both the United States and Mexico to produce graphene-based products.

[AveragePenny]

13 Top Marketing Stocks in 2024

https://spacecoastdaily.com/2024/06/13-top-marketing-stocks-in-2024/

The advertising and marketing industry is a cornerstone of the economy, propelling growth, sparking innovation, and enhancing market efficiency. According to Solomon Partners, global advertising growth for 2024 is projected to range from 4.6% to 7.2%, significantly higher than the 2% to 5% anticipated for 2023.

Major growth drivers include the Paris Olympics and the US elections. The highest year-over-year ad spending growth is expected in out-of-home advertising at 7.2%, followed by digital ad spending at 6.3%. However, print ad spending is expected to decline by 4.6%.

1. Meta Platforms, Inc. (NASDAQ: META)
Meta Platforms, Inc. has shown a robust performance in its digital advertisement segment. The company reported an EPS of $4.71 for Q1 2024, beating forecasts by $0.39. Revenue surged 27% year-over-year to $36.46 billion. The number of ad impressions across Meta’s Family of Apps increased by 20%, and the average price per ad rose by 6%. CEO Mark Zuckerberg emphasized the integration of AI in their ad business, enhancing app engagement and delivering more value to advertisers.

2. Bright Mountain Media, Inc. (BMTM)
Bright Mountain Media, Inc. has had an outstanding Q2 2024, with a remarkable increase in its stock price. The company, a global holding entity with investments in digital publishing, advertising technology, consumer insights, and creative media services, announced significant financial results for Q1 2024.

Revenue: Increased by $10.9 million to $12.4 million compared to $1.5 million for Q1 2023.
Gross Margin: Increased by $2.6 million to $3.1 million compared to $528,000 for Q1 2023.
Advertising Technology Revenue: Approximately $2.6 million.
Consumer Insights Revenue: Approximately $6.7 million.
CEO Matt Drinkwater attributed the success to the integration of new businesses and the strategic focus on leveraging data assets from their market research division to drive growth. This integration, combined with cost reduction efforts, has positioned Bright Mountain Media to continue expanding its advertising services and delivering high returns on advertising spend.

Douglas Baker, CEO of OTC PR Group, which represents Bright Mountain Media in the press, stated, “The impressive financial performance of Bright Mountain Media underscores the effectiveness of their strategic initiatives and the robust growth potential in their advertising technology and consumer insights divisions.”

3. Amazon.com, Inc. (NASDAQ: AMZN)
Amazon.com, Inc., primarily an e-commerce giant, has seen significant growth in its advertising business. For Q1 2024, Amazon reported an EPS of $1.13, beating expectations by $0.30. Revenue rose 12.5% year-over-year to $143.3 billion. Notably, the company’s advertising revenue jumped 24% to $11.8 billion. CEO Andy Jassy highlighted the success of sponsored products and the potential of Prime Video ads to link streaming TV advertising to business outcomes.

4. Criteo S.A. (NASDAQ: CRTO)
Criteo S.A., based in France, provides marketing and monetization services including contextual and video advertising. The company’s Q1 2024 earnings included a non-GAAP EPS of $0.80 and revenue of $450 million. Hedge fund interest in Criteo remains strong, with 15 funds holding stakes worth $288.761 million. Criteo’s average analyst price target suggests a 12.57% upside, making it a compelling investment.

5. Alphabet Inc. (NASDAQ: GOOG)
Alphabet Inc., the parent company of Google, posted a strong Q1 2024 with an EPS of $1.89, exceeding estimates by $0.38. The company’s revenue increased by 15.4% year-over-year to $80.54 billion. Google’s advertising segment generated $61.66 billion, and YouTube ads brought in $8.09 billion. CEO Sundar Pichai highlighted the role of AI in enhancing ad performance and cloud services, pointing to significant growth opportunities.

6. Perion Network Ltd. (NASDAQ: PERI)
Perion Network Ltd., an Israeli digital advertising solutions provider, reported Q1 2024 earnings with a non-GAAP EPS of $0.44 and revenue of $157.8 million, surpassing estimates. The company’s average price target indicates a 27.66% upside, driven by its innovative advertising solutions and strong financial performance.

7. Ziff Davis, Inc. (NASDAQ: ZD)
Ziff Davis, Inc. is a digital media and internet company known for its marketing services. The company reported a Q1 2024 non-GAAP EPS of $1.27 and revenue of $314.5 million. With an average analyst price target upside of 42.48%, Ziff Davis is a top pick for investors. The company’s strategic focus on digital media and performance marketing positions it for continued growth.

8. LiveRamp Holdings, Inc. (NYSE: RAMP)
LiveRamp Holdings, Inc. operates a marketing technology platform offering people-based marketing solutions. The company’s stock has seen a 34.24% gain over the past year, with an average analyst price target suggesting a 43.39% upside. LiveRamp’s trailing twelve-month EPS growth of 87.35% underscores its strong financial performance and growth potential.

9. National CineMedia, Inc. (NASDAQ: NCMI)
National CineMedia, Inc. runs a cinema advertising network and reported Q1 2024 earnings with a non-GAAP EPS of -$0.19 and revenue of $37.4 million, growing by 7.2% year-over-year. With a 33.04% average price target upside, National CineMedia is poised for growth, driven by its unique position in the entertainment advertising market.

10. Integral Ad Science Holding Corp. (NASDAQ: IAS)
Integral Ad Science is a global leader in digital ad verification, offering solutions to ensure ad viewability and brand safety. The company’s innovative technology and strong market position make it a valuable addition to any portfolio focused on marketing stocks.

11. Nexxen International Ltd. (NASDAQ: NEXN)
Nexxen International provides comprehensive advertising solutions, including programmatic buying and advanced analytics. The company’s commitment to leveraging cutting-edge technology positions it well for future growth, with analysts predicting significant upside potential.

12. Boston Omaha Corporation (NYSE: BOC)
Boston Omaha Corporation is involved in a diverse range of businesses, including advertising and insurance. The company’s strategic investments and robust financial health make it a top contender in the marketing and advertising sector.

13. The Trade Desk, Inc. (NASDAQ: TTD)
The Trade Desk, Inc. offers a cloud-based platform for marketers to manage digital advertising campaigns. The company’s stock is well-regarded among hedge funds, with 41 funds holding positions valued at $1.31 billion as of Q4 2023. RBC Capital recently raised the price target for The Trade Desk to $110 from $105, highlighting its strong performance and potential for future growth.

Conclusion
The advertising and marketing industry is poised for significant growth in 2024, driven by key events such as the Paris Olympics and the US elections. With digital ad spending expected to rise by 6.3% and out-of-home advertising by 7.2%, companies in this sector have substantial opportunities for revenue growth. The integration of AI technologies, as emphasized by leaders like Meta’s Mark Zuckerberg and Alphabet’s Sundar Pichai, is set to revolutionize ad engagement and efficiency. This evolving landscape presents promising prospects for investors, making stocks like Meta Platforms, The Trade Desk, Amazon, and Bright Mountain Media compelling options for those looking to capitalize on the sector’s upward trajectory.

[AveragePenny]

GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, VTAK, INBS, PRSO, AMC

https://thestreetreports.com/gamestop-raises-2-14-billion-meme-stocks-buzz-fuels-gains-watch-gme-vtak-inbs-prso-amc/

GameStop Corp (NYSE: GME) announced it had raised approximately $2.14 billion through a share sale, positioning the company for potential mergers and acquisitions. The capital infusion opens up various strategic opportunities that GameStop hinted might be forthcoming. Investor confidence surged as stock influencer Keith Gill, known as “Roaring Kitty,” indicated he maintained a significant stake in GameStop. A spike in trading of short-dated GameStop options on Wednesday led some market participants to speculate that Gill may have sold some of his recently-disclosed option’s position in the company.

Peraso (NASDAQ: PRSO) emerges as Leading Player in Fast-Growing mmWave Technology Market, gaining recognition in this expanding mmWave technology sector. The stock surged 17.32% to close at $1.49 with a volume of 246,526 shares on Wednesday June 12, 2024. Ladenburg Thalmann, a renowned Wall Street firm since 1876, identifies Peraso as a significant yet undiscovered leader in this emerging field. The global mmWave market hit $3.75 billion in 2023 and forecasts suggest that the adoption of mmWave technology in consumer sectors could drive a market shift, with a projected compound annual growth rate (CAGR) of approximately 40% expected to exceed $55 billion through 2030. For more insights, read the full report.

Catheter Precision Inc. (NYSE American: VTAK) amedical device company, in Healthcare Electrophysiologystands out as a notable player in the healthcare electrophysiology sector, Gains Momentum on Wednesday (Write about the trading Closed at .60 up 9.83% on 1,341,161 share volume hitting a high of .80 in afterhours trading.) The company is renowned for its two key products: VIVO™, aiding in ventricular arrhythmia source detection pre-procedure, and LockeT, a closure retention device. Read Entire Update Now!

Intelligent Bio Solutions Inc (NASDAQ: INBS) experienced a stock surge on June 12, 2024, closing up 13.13% with 100,460 shares traded, as New European Client Adopts their Drug Screening System, making it an opportune moment to examine INBS stock more closely. The client will use INBS’s Intelligent Fingerprinting Drug Screening System to monitor employee fitness for duty in the United Kingdom. Previously relying on third-party urine testing, the shift to Intelligent Bio Solutions underscores a paradigm shift in the drug testing healthcare sector and the client’s commitment to operational efficiency.

AMC Entertainment (NYSE: AMC) delivered a positive surprise with its first-quarter earnings, garnering praise from multiple analysts. The revival of meme stock trading enthusiasm has helped AMC stock retain many of its recent gains. With the potential for several summer blockbusters to hit theaters soon, there is speculation for a similar performance when AMC Entertainment releases its earnings in August.

[AveragePenny]

Exploring Top NASDAQ Stocks Under $1 Gaining Traction: KITT, AEMD, VTAK, TELL, KWE


https://thestreetreports.com/exploring-top-nasdaq-stocks-under-1-gaining-traction-kitt-aemd-vtak-tell-kwe/

The NASDAQ, one of the world’s largest stock exchanges, witnesses billions in daily trades across diverse stocks. Among various stock categories, penny stocks trading under $1 a share are particularly noteworthy. This article delves into five such NASDAQ-listed stocks, offering insights and potential investment opportunities.

Nauticus Robotics Inc. (NASDAQ: KITT) reports Q1 2024 Financials: First Commercial Revenue, Significant Turnaround in Net Income” on May 13. This marks the first time Nauticus Robotics generated revenue from commercial sources. The company achieved a net income in Q1, a notable improvement from a $14.1 million net loss in the prior year quarter and a $39.3 million net loss in the previous quarter.

Aethlon Medical Inc. (NASDAQ: AEMD), announces progress on hemopurifier clinical trials” On June 3, a medical therapeutic company focused on cancer and life-threatening diseases, provided a crucial update on its hemopurifier product. The company reported ongoing advancements in preparation for its phase 1 feasibility, safety, and dose-finding clinical trials in Australia and India. Aethlon Medical is set to finalize clinical trial agreements upon receiving Ethics Committee approval.

Catheter Precision Inc. (NYSE American: VTAK) a medical device, Gains Momentum in Healthcare Electrophysiology and stands out as a notable player in the healthcare electrophysiology sector. The company is renowned for its two key products: VIVO™, aiding in ventricular arrhythmia source detection pre-procedure, and LockeT, a closure retention device. Catheter Precision Inc. (NYSE American: VTAK) announced that Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego, the University of California San Diego (UCSD) health system and HCA Healthcare Inc. (NYSE: HCA) all making initial purchases of their LockeT product. HCA Healthcare Inc., a leading provider of healthcare services in the United States, generating over $64 billion in revenue in 2023. Read Entire Update Now!

Tellurian Inc. (NYSE American: TELL) is a US-based independent oil and gas exploration and production company, developing a portfolio of natural gas production. On May 29, 2024, Tellurian and Aethon Energy Management LLC announced a $260 million deal for Aethon to acquire Tellurian’s upstream assets and purchase two million tons per annum of liquefied natural gas (LNG) from Tellurian’s Driftwood LNG plant. This acquisition expands Aethon’s presence in Louisiana’s Haynesville and Bossier shale basins with 31,000 net acres and systems handling up to 100 million cubic feet per day, boosting Aethon’s capacity to over 3 Bcf/d. The transaction, expected to close in Q2 2024, supports Driftwood LNG’s financing and helps Tellurian reduce borrowings and fund corporate purposes.

KWESST Micro Systems Inc. (NASDAQ: KWE) announced securing a subcontract from Thales Canada. According to the agreement, KWESST will provide specialized software services for the Canadian Department of National Defence’s Land C4ISR program, aimed at modernizing the Canadian Army. This initiative includes deploying advanced land command, intelligence, control, communications, surveillance, and reconnaissance systems. The contract was officially signed on June 4, 2024.

[AveragePenny]

Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones: TELL, DYAI, PRSO, SPEC, INBS

https://thestreetreports.com/spotlight-june-2024-nasdaq-stocks-under-2-achieving-major-milestones-tell-dyai-prso-spec-inbs/

In recent days, a surge of interest has spotlighted several key companies, capturing significant attention from investors. This feature delves into a detailed analysis of five standout firms, offering insights that could prove crucial for investors in the near future.

Tellurian Inc. (NYSE American: TELL) is a US-based independent oil and gas exploration and production company, developing a portfolio of natural gas production. On May 29, 2024, Tellurian and Aethon Energy Management LLC announced a $260 million deal for Aethon to acquire Tellurian’s upstream assets and purchase two million tons per annum of liquefied natural gas (LNG) from Tellurian’s Driftwood LNG plant. This acquisition expands Aethon’s presence in Louisiana’s Haynesville and Bossier shale basins with 31,000 net acres and systems handling up to 100 million cubic feet per day, boosting Aethon’s capacity to over 3 Bcf/d. The transaction, expected to close in Q2 2024, supports Driftwood LNG’s financing and helps Tellurian reduce borrowings and fund corporate purposes.

Dyadic International Inc. (NASDAQ: DYAI), a renowned biotech firm specializing in large-scale protein manufacturing for therapeutics, vaccines, and non-medical applications, recently reached a milestone. On June 7, Dyadic’s stock soared to $2.67 per share, marking its highest level in 52 weeks and representing a remarkable 103% increase from its 52-week low of $1.19 per share. The bird flu outbreak has spotlighted Dyadic due to its ongoing vaccine development efforts. Additionally, Dyadic has emerged as a trending ‘meme stock,’ gaining attention alongside AMC Entertainment (NYSE: AMC), GameStop Inc. (NYSE: GME), and Novavax (NASDAQ: NVAX).

Peraso Inc. (NASDAQ: PRSO), the global leader in mmWave technology, announced a major milestone on June 4, achieving ISO 9001-2015 certification. This certification underscores Peraso’s dedication to customer satisfaction and quality in the manufacturing and design of mmWave solutions, signaling a potential paradigm shift in the wireless communication industry. Additionally, on May 14, Peraso reported its first fiscal quarter results, posting revenues of $2.8 million, a notable increase from the previous quarter’s $1.8 million. The company’s GAAP net loss was significantly reduced to $2 million, down from $8.9 million in the prior quarter. Peraso Participating at the 16th Annual CEO Investor Summit on July 10, 2024.

Spectaire Holdings Inc. (NASDAQ: SPEC), a frontrunner in mass spectrometry solutions, announced on June 10 the purchase order and delivery of its advanced AireCore units. These units were delivered to American Ag Energy, a Boston-based company renowned for converting agricultural waste into gaseous fuel for gas-fired equipment. The integration of Spectaire’s AireCore units into American Ag’s product gas analysis loop marks a significant milestone for Spectaire Holdings, as highlighted in their recent news release.

Intelligent Bio Solutions Inc. (NASDAQ: INBS), renowned for its rapid, non-invasive, and intelligent testing solutions, made a significant announcement on May 29. The medical technology company revealed that it has successfully completed the recruitment and screening of subjects for its pharmacokinetic (PK) study, advancing its FDA evaluation process in the United States. Intelligent Bio Solutions continues its diligent efforts to meet the stringent standards set by the FDA.

[AveragePenny]

June 2024 Spotlight Stocks Under 10¢ Amid Recent Developments: CYN, HNRC, PRST, RJDG, SLNA

https://thestreetreports.com/june-2024-spotlight-stocks-under-10%c2%a2-amid-recent-developments-cyn-hnrc-prst-rjdg-slna/

With several companies emerging as key players amid recent developments, it can be challenging for investors to monitor all stock movements. This feature offers an in-depth look at five noteworthy companies that investors should keep on their radar right now.

Cyngn Inc. (NASDAQ: CYN) revolutionizes autonomous vehicle industry with groundbreaking AI technology. On June 10, 2024, the company announced the successful deployment of its advanced autonomous driving system in a fleet of industrial vehicles. This cutting-edge AI technology enhances vehicle navigation, reduces downtime, and boosts productivity, marking a significant milestone for the company and the industry. Cyngn’s innovative approach continues to position it as a leader in the autonomous vehicle sector.

Houston Natural Resources (OTC: HNRC) Posts Strong Q1 Financial Results with Revenue and Earnings Growth. In May 2024 the company captured market attention by announcing robust financial results for the fiscal quarter ending March 31, 2024. The oil and natural gas firm reported impressive revenues of $4,292,940, marking a 2.7% increase from $4,178,580 in the same period last year. Total earnings also saw a notable rise, reaching $2,736,961, up 2.8% from $2,660,713 year-on-year. In addition to revenue and earnings growth, Houston Natural Resources Corporation reported a net asset value (NAV) of $0.27 per share for the quarter, underscoring the company’s solid financial position and ongoing potential for investors. This performance highlights the company’s steady upward trajectory in the competitive oil and natural gas sector.

Presto Automation Inc. (NASDAQ: PRST), a leading provider of AI and automation technology in the restaurant industry, announced a major development on June 3. The company revealed its collaboration with Qu and Taco John to launch the Presto Voice drive-thru pilot at select Taco John locations. Presto Voice aims to enhance drive-thru staff productivity by significantly reducing order-taking time.

RJD Green Inc. (OTC: RJDG) Records Landmark Revenue for Silex Holdings Inc. in May 2024. on June 5, 2024, a significant milestone for its business division, Silex Holdings Inc. The company reported its highest monthly revenues since its inception in 2006. In May 2024, Silex Holdings achieved revenues of $865,730 and a net operating profit of $242,404. This remarkable performance constitutes 18.1% of the average annual income of $4.8 million recorded over the past two years. The surge in revenue is attributed to Silex Holdings’ exceptional performance in the commercial market, while also maintaining steady growth in the retail and housing sectors. This robust financial result highlights the effective strategies and dedicated efforts of the Silex team.

Selina Hospitality PLC (NASDAQ: SLNA), announced June 10, 2024, in collaboration with the Inter-American Development Bank (IDB) Group’s innovation arm, IDB Lab, and TechnoArt, announced the launch of the Miami LAC Gateway. This groundbreaking initiative is the first program of its kind, designed to serve as a pivotal entry point for Caribbean and Latin American companies looking to expand into the U.S. market. Simultaneously, the Miami LAC Gateway will provide U.S.-based companies with invaluable opportunities to penetrate the Caribbean and Latin American markets. This initiative aims to foster economic growth, innovation, and cross-regional business collaborations, marking a significant milestone in international business development.

[AveragePenny]

Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX

https://thestreetreports.com/meme-stocks-surge-led-by-roaring-kitty-and-social-media-buzz-on-reddit-nyse-rddt-gme-dyai-amc-prso-nvax/

Market activity has picked up, with meme stocks outperforming broader market trends. Interest in these stocks has surged, largely driven by the online influencer known as “Roaring Kitty,” who ignited a social media frenzy on Reddit Inc. (NYSE: RDDT) involving GameStop (NYSE: GME) previously. Currently trending stocks on Yahoo Finance include GameStop (NYSE: GME), AMC Entertainment (NYSE: AMC), Dyadic International Inc. (NASDAQ: DYAI), Novavax Inc. (NASDAQ: NVAX), and Peraso Inc. (NASDAQ: PRSO), among others.

GameStop (NYSE: GME) saw a value surge last week following the announcement of a successful equity offering. The company raised $933.4 million by selling 45 million shares. This capital injection is expected to bolster GameStop’s financial stability and support its ongoing strategic transformation efforts.

Dyadic International Inc. (NASDAQ: DYAI), a biotech company specializing in protein manufacturing for vaccines, therapeutics, biofuels, and next-gen foods, hit a new 52-week high of $2.42 on May 30, 2024, up 103% from its low of $1.19. The stock’s 50-day and 200-day moving averages are $1.6631 and $1.6521, forming a “Golden Cross” on May 30, 2024, and showing a “Jack in the Box” pattern with a Bullish Swing Set-Up on May 31, 2024. With the bird flu outbreak escalating, the U.S. government is discussing an avian flu vaccine with Moderna (NASDAQ: MRNA). Companies like Pfizer (NYSE: PFE), Novavax (NASDAQ: NVAX), BioNTech (NASDAQ: BNTX), and Dyadic International Inc. NASDAQ: DYAI are potential collaborators. Dyadic’s COO, Joe Hazelton, talked about the bird flu threat, the company’s expansion into next-gen foods, and the “Food vs. Fuel” debate on “The Street Reports Podcast.” Listen now for more insights and for the latest developments in more detail, read more.

AMC Entertainment Holdings, Inc. (NYSE: AMC) has experienced a significant short squeeze over the past few weeks, with the stock rising approximately 45% since May 10, 2024. Last month, the company raised $250 million by selling 72.5 million shares.

Pesaro Inc. (NASDAQ: PRSO) Recently, Panasonic System Networks R&D Lab Co. Ltd. (PSNRD) has chosen its X710 chipset for a new 60GHz WLAN solution. This integration will enable wireless communication with low latency and high speeds, similar to a wired LAN, over hundreds of meters. The selection of Pesaro’s chipset by Panasonic, a global leader in consumer and enterprise technology, is seen as a significant endorsement of Pesaro’s technology. Additionally, on June 4, Pesaro announced that it has achieved ISO 9001-2015 certification, a global quality management standard that underscores the company’s commitment to customer satisfaction and quality in its mmWave solutions and products. These advancements could represent a significant paradigm shift in the wireless communication industry.

Reddit Inc. (NYSE: RDDT) commenced trading on the NYSE on March 21, 2024, following its IPO at $34. As of today, June 5, 2024, the stock closed above $60, marking a 76% increase since its debut. The IPO raised $750 million for the company.

[AveragePenny]

Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV

https://thestreetreports.com/nasdaq-stocks-soaring-to-the-top-with-strategic-splits-nvda-inbs-jagx-sint-gwav/

Investor interest shifting towards certain companies in the coming days due to recent developments. This article highlights five companies poised to attract attention.

Nvidia Inc (NASDAQ: NVDA) will execute a stock split at the market’s close on Friday, June 7, 2024. If you were a shareholder of record holding common stock as of the market’s close on Thursday, June 6, you will receive an additional nine shares of NVDA for each share you previously held. This marks the sixth forward stock split in the company’s history. Nvidia’s strong financials and approaching $3 trillion market cap could surpass Apple Inc. (NASDAQ: AAPL), whose market cap surged after their last stock split.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) experienced significant growth, providing innovative, rapid, non-invasive drug testing solutions to over 400 customers across 15+ industries in the UK. In the nine months ending March 31, 2024, revenue reached approximately $2.38 million, marking a 193% year-over-year increase, with the UK contributing around 93%. High-margin cartridge sales accounted for about 49% of total revenue. Over the 12 months ending March 31, 2024, the company acquired 111 new accounts. The successful adoption in the UK suggests promising potential for Intelligent Bio Solutions in the US, pending its planned FDA 510(k) submission and anticipated product launch in early 2025. The stock price surged to an intraday high 11.70 and a closing high of $6.77 in February 2024 following their stock split on January 29, 2024.

Jaguar Health Inc (NASDAQ: JAGX) after a stock split on May 23, 2024, the company announced on May 29 that it had signed an out-licensing agreement with its joint venture firm Magdalena Biosciences Inc. This joint venture, formed with Filament Health Corp, focuses on developing unique, natural prescription plant-derived medicines for mental health issues. Jaguar Health revealed that the collaboration’s scope had expanded to include the development of a prescription botanical drug candidate for treating schizophrenia. The news release highlighted that, according to the agreement, the company would also receive royalties from sales in the United States schizophrenia market, which could reach a valuation of $8.06 billion by 2030.

SINTX Technologies Inc (NASDAQ: SINT), after a stock split on May 23, 2024, this manufacturer and developer of advanced ceramic materials and related technologies, was in the spotlight on May 29 following a significant announcement. SINTX Technologies revealed that it had entered into a 5-year strategic agreement with Myosung Co Ltd. Under this agreement, Myosung would represent SINTX Technologies’ interests in Korea, focusing on cultivating clients in the technical ceramic products space. The announcement highlighted that SINTX Technologies offers a significantly differentiated and novel product range in the technical ceramics industry. Myosung decided to support the company’s Korean expansion after being suitably impressed during previous collaborations.

Greenwave Technology Solutions Inc (NASDAQ: GWAV), a metal recycling company, announced on May 29 that it would implement a reverse stock split. The reverse stock split, effective on May 31, 2024, would be executed at a 1-for-150 ratio. In the news release, the company stated that this move aimed to boost the trading price per share and meet NASDAQ’s minimum bid price requirements to remain listed on the exchange. It was also revealed that the stock would begin trading on a split-adjusted basis starting June 3, 2024.

[AveragePenny]

Spotlighting Noteworthy Companies, Insights and Recent News Cycles: FFIE, VTAK, ASTI, BNED, PEGY

https://thestreetreports.com/spotlighting-noteworthy-companies-insights-and-recent-news-cycles-ffie-vtak-asti-bned-pegy/

Recent news cycles have highlighted several companies, making it an opportune moment to delve deeper into some of them. This feature offers insights into five noteworthy companies.

Faraday Future Intelligent Electric Inc (NASDAQ: FFIE): Shows Bullish Indicators Post-Surge: On May 9, 2024, we highlighted this stock under $0.10 (Stocks on The Street Under 10¢ in Focus: FFIE, SPZI, HNRC, PEGY, HALB (https://thestreetreports.com/stocks-on-the-street-under-10%c2%a2-in-focus-ffie-spzi-hnrc-pegy-halb/ ). The stock then surged over $3. After a recent pullback, FFIE is showing bullish indicators and returning to an upswing. In Monday’s trading session, the stock increased by over 40% since Wednesday May 29, 2024, making it a stock worth monitoring.

The medical device sector in the healthcare industry has rapidly advanced in recent years due to its inherent innovation, and Catheter Precision Inc. (NYSE American: VTAK) Gains Momentum in Healthcare Electrophysiology andstands out as a notable player in the healthcare electrophysiology sector. The company is renowned for its two key products: VIVO™, aiding in ventricular arrhythmia source detection pre-procedure, and LockeT, a closure retention device. Catheter Precision Inc. (NYSE American: VTAK) announced that Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego, the University of California San Diego (UCSD) health system and HCA Healthcare Inc. (NYSE: HCA) all making initial purchases of their LockeT product. HCA Healthcare Inc., a leading provider of healthcare services in the United States, generating over $64 billion in revenue in 2023.Read Entire Update Now!

Ascent Solar Technologies (NASDAQ: ASTI), a leading U.S. innovator in flexible, durable, and lightweight CIGS thin-film PV (photovoltaic) solutions, announced on May 16 the development of a solar array prototype. This development is in collaboration with the University of Stuttgart Institute for Building Energetics, Thermotechnology, and Energy Storage (IGTE). The partnership with this global research center focuses on renewable energy, energy storage, and indoor climate technology. Ascent Solar may also ship its ultra-light, thin-film, long-lasting technology this summer to meet IGTE’s timeline for developing storage and power collection systems.

Barnes & Noble Education Inc. (NASDAQ: BNED) made headlines on May 23 after announcing its financial results for the fiscal year ending April 27, 2024. The company reported consolidated revenues of approximately $1567 million, an improvement from $1543 million the previous year. The net loss from continuing operations decreased to $63 million from $90 million in the prior year. The consolidated non-GAAP adjusted EBITDA surged to about $45 million, up from just $8 million the previous year. These financial results are preliminary and unaudited. The company also revealed its continued efforts on planned transactions aimed at significantly deleveraging its balance sheet.

Pineapple Energy Inc. (NASDAQ: PEGY): On May 30, the interim Chief Executive Officer, Scott Maskin, reaffirmed the board of directors’ commitment to retaining Eric Ingvaldson as Chief Financial Officer, a position he has held since October 2022. The company also announced in its news release that the board appointed seasoned executive James Brennan as Chief Operating Officer. Brennan, who has been the Senior Vice President of Corporate Development at Pineapple Energy since November 2022, will now help steer the company’s operations. Pineapple Energy emphasized its focus on building leadership with long-term goals in mind.

[AveragePenny]

Spotlight: Peraso Inc. (NASDAQ: $PRSO ) A Semiconductor Valued Stock In Focus

https://www.openpr.com/news/3508939/spotlight-peraso-inc-nasdaq-prso-a-semiconductor-valued

Peraso Inc. (NASDAQ: PRSO), a prominent player in mmWave technology for 5G licensed and 60 GHz unlicensed networks, disclosed its financial outcomes for the initial fiscal quarter concluding on March 31, 2024, on May 13. The company revealed total net earnings of $2.8 million, contrasting with $1.8 million in the preceding quarter and $5 million in the corresponding period of the prior year.

Image: https://www.abnewswire.com/uploads/ab52a2e3727e2c3a192fc9b4209229c4.jpg

During the first quarter, product revenues amounted to $2.7 million, marking an increase from $1.5 million in the previous quarter and $4.9 million in the prior year. The company attributed the sequential revenue growth to heightened shipments of memory IC and mmWave products, as stated in the press release.

Despite a quarterly loss of $0.83 per share, this figure was below the Zacks consensus projection of a $1.26 per share loss, resulting in a significant positive earnings surprise of 34.13%. Over the last year, the company has exceeded the consensus earnings per share estimates twice. In the corresponding quarter of the previous year, Peraso had incurred a loss of $3.60 per share.

Peraso announced that its CEO, Ron Glibbery, and CFO, Jim Sullivan, are scheduled to deliver presentations at the Lytham Partners 2024 Virtual Spring Conference on May 30 at 11:45 a.m. Eastern Time. The company mentioned that its management team would be accessible for virtual meetings with investors attending the event throughout the day. Additionally, Peraso stated that a live webcast and archived version of the management's presentation, along with supplementary materials, will be accessible on the Events & Presentations page of the company's website.

Active across these sectors, Technology Semiconductor Sector Companies Under $10 include: United Microelectronics Corp (NYSE: UMC), Himax Technologies, Inc. (NASDAQ: HIMX), Arteris Inc (NASDAQ: AIP), Magnachip Semiconductor Corp (NYSE: MX), ASE Technology Holding Co., Ltd. (NYSE: ASX), Navitas Semiconductor Corporation (NASDAQ: NVTS), and NVIDIA Corporation (NASDAQ: NVDA) reports earnings after the market close today.

[AveragePenny]

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers


https://thestreetreports.com/intelligent-bio-solutions-inc-nasdaq-inbs-advancing-us-fda-process-featured-among-top-health-care-movers/

Intelligent Bio Solutions Inc. (NASDAQ: INBS), a medical technology company, offers rapid, intelligent, and non-invasive testing solutions. On May 29, the company announced its success in recruiting and starting the screening of subjects for its pharmacokinetic (PK) study. This study is a crucial step in Intelligent Bio Solutions’ FDA 510(k) regulatory clearance process. The dedicated team worked diligently to ensure the study’s design met FDA standards.

On Thursday, May 30, 2024, INBS closed up 5.68% on lower-than-normal volume, triggering a Stochastic Buy Signal, a bullish indicator suggesting the stock is oversold and may present a buying opportunity. Additionally, Intelligent Bio Solutions Inc. (NASDAQ: INBS) was highlighted among Health Care Stocks in Thursday’s After-Market Session Movers by Benzinga, along with OneMedNet Corp (NASDAQ: ONMD), Abeona Therapeutics Inc. (NASDAQ: ABEO), BiomX Inc. (NYSE: PHGE), MyMD Pharmaceuticals Inc. (NASDAQ: MYMD), and Adaptimmune Therapeutics (NASDAQ: ADAP) among others, Read more.

The PK study aims to offer a detailed understanding of opiate metabolism, distribution, and excretion, particularly in human sweat. Human fingerprint sweat specimens will be collected and analyzed as part of the study. The results will be compared with those from urine, blood, and saliva specimens. The company’s Intelligent Drug Screening System leads in non-invasive drug screening solutions. Intelligent Bio Solutions expects the PK study to be completed in June.

On May 23, Intelligent Bio Solutions announced key performance indicators from its UK operations, highlighting significant growth in the drug screening sector. For the nine months ending March 31, 2024, the company reported $2.38 million in revenue, a 193% year-over-year increase, with 93% from UK operations. High-margin cartridges accounted for 49% of total revenue. Intelligent Bio Solutions provided fast, intelligent, and non-invasive drug testing to over 400 UK customers across 15 industries, acquiring 111 new accounts in the 12 months ending March 31, 2024. B2B referrals significantly drove this growth.

[AveragePenny]

$BSEG 3 Cent/Share Big Screen Entertainment Group Positioned to be Star Stock Performer

https://richardacavalli.wixsite.com/greenplanetmicrocaps/3-cent-entertainment-star-stock

Big Screen Entertainment Group has been in business since 2005 and is now entering a rapid growth phase with a very popular Marilyn Monroe story in production

Big Screen Entertainment Group has 31 Movies in the can and over 300 titles in distribution and growing

Marilyn Monroe is one of the most popular film subjects in history and the new Marilyn Monroe series by Big Screen Entertainment Group could send BSEG shares soaring. This new series will air information about Marilyn Monroe that has never been aired

Big Screen Entertainment Group has its own distribution platform called Big Stream that distributes through Roku, iTunes, Tubi (owned by Fox), You Tube, Hulu, Shutter, Netflix, Hallmark, Amazon Prime, Paramount and more

Big Screen Entertainment has a 90,000 sq ft production facility in the City of Commerce, Los Angeles and recently launched the Big Film Fund to produce films in the biggest revenue categories

Attractive revenue growth projections and big potential upside with share price at only 3.3 cents and small market cap of $3.7 million

Low-budget movies can yield massive profits, sometimes even more so than big-budget blockbusters. This is because low-budget films typically have much lower production costs, which means they don't need to make as much money to turn a profit.

Additionally, low-budget films often cater to niche audiences or explore unique storytelling approaches, which can generate strong word-of-mouth buzz and dedicated fan followings. This grassroots support can lead to significant returns on investment, as seen in the success of independent films like "The Blair Witch Project" or "Paranormal Activity," which were made on shoestring budgets but went on to earn millions at the box office.

Furthermore, with the rise of digital distribution platforms and alternative distribution models, low-budget filmmakers have more avenues than ever to reach audiences directly, reducing marketing and distribution costs while maximizing profits. So, while big budgets can certainly help with spectacle and scale, there's a lot to be said for all the reasons above, Big Screen Entertainment Group (BSEG: OTC) stands out as one of the greatest opportunities to invest in a 3.3 cent stock with a total market capitalization of under $4 million.

New Marilyn Monroe Series in Production Could Send BSEG Shares Flying

The entertainment industry is big and streaming is catapulting revenues even higher. Sales are frequently driven by star power. Names can be everything. Marilyn Monroe is a classic example of a name that continues to draw large numbers of all ages as evidenced by over 7 billion clicks about her on Tik Tok.

Fast-growing, Big Screen Entertainment Group is beginning to make waves in the entertainment industry and recently announced that is thrilled to unveil its latest TV show in production, the highly anticipated unscripted series, “Hollywood Legends: Marilyn Monroe.” A mesmerizing eight-part exploration of Marilyn Monroe's extraordinary life delves into the many fascinating facets of this timeless Hollywood icon, capturing the essence of her undeniable talent and enduring stardom which continues to attract audiences worldwide. This epic documentary was filmed at historic locations across Los Angeles and uncovers hidden stories and untold secrets that shaped Marilyn's journey to superstardom.

Hollywood Legends will premiere exclusively on Big Stream Entertainment, BSEG's cutting-edge streaming platform that boasts a vast library of films, documentaries, and specials, including several featuring Monroe herself. Available on Roku, online, or on your Android device via the Google Play store, Big Stream offers hundreds of hours of captivating content.

“Hollywood Legends: Marilyn Monroe” is produced by BSEG's Chief Executive Kimberley Kates, who said: “Through this show, we pay homage to Marilyn's enduring legacy, presenting her as the trailblazing woman she was—always ahead of her time and an inspiration to millions.”

The Marilyn Monroe documentary will provide new information about Marilyn Monroe that has never been aired and is expected to draw large audiences. Hollywood Legends is just the tip of the iceberg for Big Screen Entertainment Group. The entertainment industry is dominated by industry giants such as Disney, Netflix, Warner Brothers, Roku, Paramount and others, but relatively unknown Big Screen Entertainment Group is quickly establishing itself as a serious contender for large audiences to enjoy a broad spectrum of the most popular categories of films. Big Screen Entertainment Group is guided by Kimberley Kates, who is experienced both in front of the camera and behind the camera where the rubber hits the road to success. There are several moving parts to the movie business and Kimberley Kates knows exactly which paths to take to success.

Demand for the soon upcoming Marilyn Monroe series is expected to be so large that Big Screen announced it is also producing and releasing a Feature Length Documentary about Marilyn Monroe with footage never seen before that is sure to draw large audiences across the globe.

Big Screen Entertainment Group is an innovative entertainment provider that is focused on creating not only popular and attractive projects but is equally focused on generating profits for its shareholders.

Kimberly Kates, CEO - Big Screen Entertainment Group

An important message from Kimberley Kates is, “We have a new line up of projects to make of 28 films from Hallmark to Horror to Faith based. We’ve been optioning scripts from top Hollywood writers the last 2 years. Our current focus for our films is not only to entertain, but also to shed inspiration hope and light in a somewhat dim world. Much of our new IP’s, scripts are about love, light and laughter. Our current slate of projects have that Spielberg touch: Heart, that Hollywood’s been missing for a while now.”

PREVIOUS WORK

BSEG's accomplished producers know how to make big hits and have been instrumental in leading successful projects like Terrifier 2 (Horror, budget $500K, grossing $50M), The Queen (Drama, budget $10M, grossing $125M), Step Up (Romcom, budget $8M, Grossing $120M).

TALENT

Boasting over 200 years of collective experience, the Big Screen Entertainment Group team has managed extensive film and TV programming featuring big names such as Meryl Streep, Bruce Willis, Vin Diesel, Jenny McCarthy, Christian Bale, and Woody Harrelson, thereby driving substantial profits for their clients.

ONE SINGLE PROJECT CAN CATAPULT BIG SCREEN ENTERTAINMENT GROWTH – THERE ARE SEVERAL

Big Screen Entertainment has a large pipeline of films coming to the screen and a list can be seen here.

BIG FILM FUND

Big Screen Entertainment is seeking to launch its own film equity crowdfunding platform, the Big Film Fund, which will be owned by the company. In order to build this platform, BSEG is seeking investment in its common stock which is quoted on the OTC (Ticker: BSEG). BSEG has set a maximum raise of only $500,000 for accredited investors only.

REVENUE STREAMS

Big Screen Entertainment Group generates revenue from a range of sources:

Distribution is on all major platforms, including DVD sales which remain stable. This has been a reliable source of revenue that the company continues to expand.

Marketing and Production: Marketing and production is another key revenue source. With a talented team in-house, Big Screen is committed to delivering high-quality product for clients.

Streaming Channel: Big Stream is an exciting area of growth to reach a wider audience and to build brand recognition with original programming. Currently Big Screen has over 300 titles and plans on expanding its library.

The Princess Network Retail: The Princess Network Retail is a profitable revenue stream and Big Screen is committed to expanding this area in the future.

Kids Education and Programming:

Big Screen is committed to providing quality content for all ages and expanding into the lucrative and in-demand area of kids' education and programming. With Big Screen - Kids and The Princess Network - Little Princesses divisions, the company is developing educational and entertaining content that parents and kids will love.

Big Screen Entertainment is dedicated to creating programming that not only entertains but also helps children learn and grow.

6. Publishing:

Big Screen is excited to have launched their publishing division with the acclaimed AVENGER FIELD as the first in the series of books. Management sees this as a promising area of growth and is committed to bringing high quality content to readers.

Audible Versions of our Books will also be available.

7. Selling IPs: Selling IPs to major studios and streamers is an area the company is actively pursuing. With the potential for significant revenue, this as an important area for growth and management is working to increase efforts in this area. The company has been actively developing new shows with teams of writers.

9. Film Production and Creation: Big Screen receives a studio fee and production fee for film production and creation work. This includes not only feature films for streamers, but also content for TV like Hallmark Channel and Lifetime. With the opportunity to retain foreign rights and sell to the rest of the world, this is an area committed to growing. This area of growth has significant potential for revenue, and we are committed to investing in the development of new and exciting content for kids. With our talented team and strong partnerships, we are confident in our ability to continue to deliver the highest quality content for kids and their families.

Conclusion

The entertainment industry is close to a $100 billion market and stellar performance by stocks like NFLX and ROKU suggest a bright future for Big Screen Entertainment Group that has tapped into the same streaming that has catapulted NFLX and ROKU. Big Screen Entertainment Group represents an opportunity to participate in a superior long-term growth business model positioning to become a large player in the entertainment industry and perhaps even more importantly, Big Screen Entertainment Group is about to launch a film about Marilyn Monroe that could be a blockbuster which could send shares flying. Shares are currently very undervalued, down from 40 cents and selling at 3.3 cents. With a tiny market cap of under $4 million which suggests a big upside potential if the company continues to be successful.

[AveragePenny]

$BIEI Premier Graphene, Inc. (OTC: BIEI) An Industry Disruptor in $11.5 Trillion Market

https://www.marketscreener.com/quote/stock/PREMIER-BIOMEDICAL-INC-120794207/news/Premier-Graphene-Inc-OTC-BIEI-An-Industry-Disruptor-in-11-5-Trillion-Market-46816377/

On May 13, 2024, Premier Graphene Inc. (OTC: BIEI) garnered attention following its disclosure of acquiring the third commercial industrial hemp license in partnership with HGI Industrial Technologies LLC. The company emphasized its endeavor to leverage local resources in the United States and Mexico for the production and research of innovative graphene-based products.

These graphene-based products are designed to cater to the substantial consumer needs across various sectors, including medical, construction, and aerospace industries. Premier Graphene Inc. previously stated that a study by a government-certified laboratory in Baja California, Mexico, validated the strategic advantages of using industrial hemp-based graphene additives in hydraulic concrete. The company expressed that the study outcomes surpassed their initial expectations. After 28 days of testing, it was confirmed that the distinctive blend developed by HGI Industrial Technologies resulted in concrete that was stronger, lighter, and provided enhanced durability, meeting the rigorous standards of the industry.

On April 17, 2024, Premier Graphene, Inc. (OTC: BIEI) announced groundbreaking achievements in combining graphene with construction materials, marking a significant breakthrough in materials science and construction. Extensive research and testing illustrated graphene's transformative potential for building materials in global infrastructure projects, particularly enhancing hydraulic concrete's quality. This advancement indicates substantial improvements in cement performance and the creation of superior concrete products.

[AveragePenny]

Intelligent Bio Solutions Inc. (NASDAQ: INBS): Research Report Update May 2024

Intelligent Bio Solutions Inc. (NASDAQ: INBS) remains on track to enter the U.S. market in 2025. Sales momentum at Intelligent Bio Solutions remained strong, with the addition of 26 new accounts in the first fiscal quarter. These new accounts included 16,779 employees. Another key aspect is that Intelligent Bio Solutions continues to enhance its intellectual property portfolio. Recently, its DSR-PLUS Cartridge Reader received a European patent for unitary use. See May 2024 Update Now!

Ladenburg Thalmann, a renowned Wall Street firm founded in 1876, issued a buy rating and target price of $12 for Intelligent Bio Solutions Inc. (NASDAQ: INBS), a leader in medical technology, is making strides with its innovative fingerprint drug testing device. This product offers a quick, efficient alternative to traditional urine or saliva tests, which can be costly, slow, and hazardous. There’s a growing need for faster, reliable, and economical drug testing solutions, especially in workplace environments. Market forecasts suggest an expansion from $5.3 billion in 2023 to approximately $28.3 billion by 2032. Intelligent Bio Solutions is set to secure a considerable market share with its pioneering fingerprint testing technology.

While focusing on operations, the company’s fundamentals have strengthened. In Q3 of FY 2024, reflecting 80% year-on-year growth. For the nine months ending March 2024, total revenues reached $2.28 million, marking a 193% increase compared to the same period last year. Strong financial health is crucial for growth-oriented companies, and Intelligent Bio Solutions is well-capitalized. Recently, the company raised approximately $10.76 million through a private placement and warrant inducement transaction. By the end of Q1 2024, the company had cash and cash equivalents of $9.40 million, significantly up from $1.1 million in the previous year’s quarter. According to The Street Reports, the company is projected to generate $73.5 million in revenues by 2028. Additionally, its IFB products have gained significant traction in European and Asian markets.

Another company standout is the medical tech firm Intelligent Bio Solutions Recent key operational developments may fuel significant future growth is a partnership with Cliantha Research for pharmacokinetic (PK) studies within the FDA’s clinical studies plan.

Active across these sectors, medical devices companies include: Perspective Therapeutics Inc (NYSEAMERICAN: CATX), Tandem Diabetes Care Inc (NASDAQ: TNDM), Pacific Biosciences of California Inc (NASDAQ: PACB), Novocure Ltd (NASDAQ: NVCR), BIOLASE Inc (NASDAQ: BIOL), ReShape Lifesciences Inc (NASDAQ: RSLS), Nano-X Imaging Ltd (NASDAQ: NNOX)

[AveragePenny]

Penny 1¢ Stocks to Watch: NSAV, HNRC, SPZI, HALB, BIEI

https://www.marketscreener.com/quote/stock/NET-SAVINGS-LINK-INC-120791870/news/Penny-1-Stocks-to-Watch-NSAV-HNRC-SPZI-HALB-BIEI-46772071/

Investors must categorize stocks and examine those featured in recent news. Significant value often lies in penny stocks, trading at 1 cent per share. This article highlights some of these noteworthy, undervalued stocks recently making headlines.

Net Savings Link Inc. (OTC: NSAV): A cryptocurrency, blockchain, and digital asset technology company, announced a major milestone for its NSAVx.com CEX exchange on May 14. Collaborating with MyAirDropAlert.com (MADA), the exchange successfully added over 500,000 users. From May 13 to the morning of May 14, 186,819 new account holders joined, bringing the total to 535,597 users through the MADA partnership.

Houston Natural Resources Corporation (OTC: HNRC): Reported Q1 earnings on May 15 with revenue of $4.29M, marking a 2.6% year-over-year increase, read more. On May 14, the company gained attention due to its minority portfolio company, Cunningham Mining Ltd., which updated the acquisition of a 19.8% stake in Kharrouba Copper Company Inc.

Spooz Inc. (OTC: SPZI): Now known as JP 3E Holdings Inc., announced on May 10 a Memorandum of Understanding with Kerogen Resources LLC to establish Kerogen Resources II LLC. This new entity will focus on developing unconventional onshore U.S. shale assets. Spooz Inc. will hold the majority stake and provide necessary financing, marking a significant move in the energy sector.

Halberd Corporation (OTC: HALB): Currently engaged in two active initiatives to mitigate and treat the effects of TBI (traumatic brain injury). On May 9, the company gained attention by aligning these initiatives with a recently passed bill in the U.S. House of Representatives. The Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, dedicated to two Marines who died by suicide, passed unanimously. Halberd Corporation's patented product, LDN+, was the focus of a study involving military veterans.

Premier Graphene Inc. (OTC: BIEI): Announced on May 13 that, in collaboration with HGI Industrial Technologies, it successfully acquired a third industrial hemp license. An independent study by a state-approved lab in Baja California, Mexico, highlighted the benefits of hemp-based graphene additives in hydraulic concrete. Premier Graphene Inc. noted that the study's results significantly exceeded its expectations.

[AveragePenny]

Market Movers on The Street: LAZR, INBS, REBN, PSRO

https://thestreetreports.com/market-movers-on-the-street-lazr-inbs-rebn-psro/Luminar Technologies (NASDAQ: LAZR) The company, which manufactures lidar sensors meant for self-driving cars, was in focus on May 8 following a key announcement. Luminar Technologies revealed that in the first fiscal quarter, Tesla was its biggest customer and made up 10% of its revenues of $21 million for the quarter. It was a significant announcement since Tesla Chief Executive Officer Elon Musk is fully committed to the success of self-driving cars. In August, Tesla aims to launch a robotaxi. In the first quarter, Luminar Technologies reported a loss of $10.46 million.

Ladenburg Thalmann, a renowned Wall Street firm founded in 1876, issued a buy rating and target price of $12 for Intelligent Bio Solutions Inc. (NASDAQ: INBS), a leader in medical technology, is making strides with its innovative fingerprint drug testing device. This product offers a quick, efficient alternative to traditional urine or saliva tests, which can be costly, slow, and hazardous. There’s a growing need for faster, reliable, and economical drug testing solutions, especially in workplace environments. Market forecasts suggest an expansion from $5.3 billion in 2023 to approximately $28.3 billion by 2032. Intelligent Bio Solutions is set to secure a considerable market share with its pioneering fingerprint testing technology. For more insights, read the full TalkMarkets article.

Reborn Coffee Inc. (NASDAQ: REBN) The California-based specialty coffee retailer announced on May 8 that it had been successful in expanding significantly in China. Reborn Coffee Inc. announced that it expanded into the Chinese market through a market license agreement with the architectural and interior design consulting firm IAID Co. Ltd. Thanks to the agreement, a flagship location in Guangzhou would be established. The outlet would also be equipped with a detailed brand center and would be the basis for future expansion into major cities in China like Shenzhen and Shanghai in the near term.

Pesaro Inc. (NASDAQ: PSRO), a leader in 60 GHz unlicensed and 5 GHz mmWave wireless technology, provides IP, antenna modules, software, and chipsets. The company made headlines on April 30 after announcing that it would release its financial results for the first fiscal quarter of 2024 on May 13, following the market’s close. Additionally, on April 16, news surfaced that Panasonic System Networks R&D Lab Co. Ltd. had integrated Pesaro’s X710 chipset into its new 60GHz WLAN connection. In a significant move on April 16, Pesaro Inc. announced that Panasonic System Networks R&D Lab Co. Ltd. has adopted its X710 chipset for a new 60GHz WLAN solution. This collaboration is notable given Panasonic’s global prominence in enterprise and consumer technology.

Catheter Precision Inc. (NYSE American: VTAK), an innovative U.S. medical device firm focused on electrophysiology products, on May 7, announced a purchase order from the University of California San Diego Health System (UCSD) for its revolutionary LockeT product. This purchase order follows another purchase order announcement on April 24 by Catheter Precision for the LockeT product, by HCA Healthcare Inc. (NYSE: HCA). HCA Healthcare Inc. is one of the largest healthcare service providers in the United States, generating revenues of $64 billion in 2023 and Ladenburg Thalmann set a target price of $4 for Catheter Precision Inc. (NYSE American: VTAK), see buy recommendation.

Dyadic International Inc. (NASDAQ: DYAI) The company reported revenues of $2,899,000 and cash, cash equivalents, and investment-level securities valued at $7.3 million at the end of the fiscal year 2023. Additionally, the company successfully concluded a $6 million capital raise, sourced from relatives, trusts, and long-standing DYAI shareholders linked to Mark Emalfarm, the company’s CEO. This infusion has bolstered the company’s robust capital position. See Zacks Small-Cap Research Report, updated April 1, 2024. Finally, CEO Mark Emalfarb highlighted Dyadic’s accomplishments on “The Street Podcast,” highlighting the $75 million DuPont (NYSE: DD) deal and drawing parallels between Dyadic and Tesla, Inc.’s (NYSE: TSLA) transformative impact on the auto industry. Listen Now!

[AveragePenny]

Houston Natural Resources (OTC: HNRC) Strengthens Global Energy Market Presence


https://thestreetreports.com/houston-natural-resources-otc-hnrc-strengthens-global-energy-market-presence/

Houston Natural Resources Corporation (OTC: HNRC) stands out as a leading entity in the oil and gas industry, marked by strategic acquisitions such as Cunningham Energy, investments in HNR Acquisition Corp. (NYSE: HNRA) and a notable stake in Rhino Energy, highlighting its expansion and growing influence globally. Particularly notable is its significant progress over the past year. While the company is branching into alternative energy, it remains a central player in the traditional oil and natural gas sectors.

A strategic decision that solidified its role in the conventional oil and gas sector was Houston Natural Resources Corporation’s recent 100% purchase of Cunningham Energy LLC. Founded in 2008, Cunningham Energy focuses on the exploration, acquisition, and production of oil and gas in the Appalachian, Williston, and Illinois Basins. A recent appraisal of Cunningham Energy’s oil and gas leases and assets was finalized. According to this assessment, as of December 31, 2022, the assets were valued at $352 million, presuming the completion of a drilling program covering 68 wells.

Another important move by Houston Natural Resources Corporation was its investment in the SPAC HNR Acquisition Corp. (NYSE: HNRA). In November 2023, HNRA finalized a business combination, transforming into an independent oil and gas company engaged in the acquisition, development, production, and exploration of oil and gas properties in the Permian Basin. Among HNRA’s assets is the Grayburg-Jackson oil field.

Houston Natural Resources recently acquired a 40% stake in Rhino Energy Pty Ltd. It’s worth noting that Rhino’s management team brings extensive global expertise, having managed energy assets in 27 countries. Additionally, Rhino has invested in a Canadian junior company that is developing its interests. Houston Natural Resources Corporation (OTC: HNRC) stock is tremendously undervalued with a 52-week high of $0.1579 currently trading at $0.02.

[Zardiw]

$GSUN Chart from #DDAmanda - #1 Stock Screener :

Find Winners Early.



Z

[AveragePenny]

Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS


https://thestreetreports.com/investor-spotlight-companies-poised-for-growth-amid-recent-developments-vtak-espr-fgen-gsun-inbs/

Given recent developments, several companies are anticipated to attract investor attention, making it an opportune moment to examine these events more closely. This feature will offer insights into five such companies.

Catheter Precision Inc. (NYSE American: VTAK), an innovative U.S. medical device firm focused on electrophysiology products, on May 7, announced a purchase order from the University of California San Diego Health System (UCSD) for its revolutionary LockeT product. This purchase order follows another purchase order announcement on April 24 by Catheter Precision for the LockeT product, by HCA Healthcare Inc. (NYSE: HCA). HCA Healthcare Inc. is one of the largest healthcare service providers in the United States, generating revenues of $64 billion in 2023.

Esperion Therapeutics Inc. (NASDAQ: ESPR), announced on May 7 its financial results for the first fiscal quarter. The company reported a net income of $61 million, with earnings of 34 cents per share, exceeding Wall Street analyst expectations. Previously, an average loss of 8 cents per share had been anticipated based on estimates from six analysts surveyed by Zacks Investment Research. The biopharmaceutical company also reported first-quarter revenues of $137.7 million, surpassing the expectations of Wall Street. Zacks Investment Research, which surveyed five analysts, had projected an average revenue of $53.1 million.

FibroGen Inc. (NASDAQ: FGEN) released its financial results for the first fiscal quarter of 2024 on May 7. The company highlighted a robust cash balance and progress in clinical trials at the quarter’s end. FibroGen reported revenues of $55.9 million but also experienced a net loss of $32.9 million for the period. Despite some challenges in its clinical trials during the quarter, the company maintained an optimistic outlook on its commercial future. Additionally, FibroGen noted that its current cash reserves are expected to sustain operations through 2026. The company expressed confidence in the commercial prospects of pamrevlumab for treating pancreatic cancer and announced the reacquisition of the U.S. rights for roxadustat, along with efforts to explore new partnerships.

Golden Sun Health Technology Group Ltd. (NASDAQ: GSUN), a provider of tutorial services in China, announced on May 7 that it had received a written notification from NASDAQ Capital Market LLC on May 3, 2024. The notification indicated that Golden Sun Health Technology Group Limited had successfully regained compliance with the exchange’s minimum bid price requirements. According to the notification letter, on May 2, 2024, the company maintained a minimum closing bid price of $1 per share for ten consecutive trading sessions.

Ladenburg Thalmann, a renowned Wall Street firm founded in 1876, issued a buy rating and target price of $12 for Intelligent Bio Solutions Inc. (NASDAQ: INBS), a leader in medical technology, is making strides with its innovative fingerprint drug testing device. This product offers a quick, efficient alternative to traditional urine or saliva tests, which can be costly, slow, and hazardous. There’s a growing need for faster, reliable, and economical drug testing solutions, especially in workplace environments. Market forecasts suggest an expansion from $5.3 billion in 2023 to approximately $28.3 billion by 2032. Intelligent Bio Solutions is set to secure a considerable market share with its pioneering fingerprint testing technology. For more insights, read the full TalkMarkets article.

[AveragePenny]

Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK


https://thestreetreports.com/breaking-on-the-street-stocks-to-watch-now-ctmx-prso-imcc-kavl-vtak/

Investors are eyeing numerous companies lately, and here’s an insight into five of them.

CytomX Therapeutics Inc. (NASDAQ: CTMX), a key player in conditionally activated masked biologic therapeutics, witnessed a remarkable 215% increase in its stock value on May 1. The company gained attention when it revealed its plan to unveil its financial results for the first quarter of 2024 on May 8, 2024, post-market closure. Additionally, CytomX Therapeutics announced that it would provide an update on the CX 904 Phase 1a dose escalation on the same day. A conference call is also scheduled for May 8 at 5 p.m. Eastern Time.

Pesaro Inc. (NASDAQ: PRSO) is a leading player in cutting-edge 60 GHz and 5G mmWave wireless technology, offering a range of solutions including software, IP, chipsets, and antenna modules. The company recently revealed that it will unveil its first fiscal quarter 2024 financial results on May 13, 2024, after the market close. Following this, a conference call featuring Jim Sullivan, the Chief Financial Officer, and Ron Glibbery, the Chief Executive Officer, will commence at 2 p.m. Pacific Time on the same day. The call will delve into the company’s business prospects and financial performance. In a significant move on April 16, Pesaro Inc. announced that Panasonic System Networks R&D Lab Co. Ltd. has adopted its X710 chipset for a new 60GHz WLAN solution. This collaboration is notable given Panasonic’s global prominence in enterprise and consumer technology.

IM Cannabis Corp. (NASDAQ: IMCC) garnered attention on May 1, with its stock surging 29% during the day due to heightened interest. As a prominent medical cannabis firm operating in Germany and Israel, IM Cannabis Corp. announced its upcoming financial results for the first quarter ending March 31, 2024, to be disclosed on May 8, 2024.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL), the exclusive distributor of Bidi Vapor LLC’s products like the BIDI® Stick for legal-aged nicotine users in the U.S., recently revealed its first-quarter fiscal 2024 financials on March 25. Revenues surged to $3.2 million from the previous year’s $2.5 million, showcasing robust growth. Notably, in 2022, Kaival Brands sealed a significant deal with Phillip Morris Products SA (NYSE: PM) for VEEBA®, a disposable vape product akin to BIDI® Stick, offering diverse global flavors and targeting convenience for legal-aged nicotine consumers. Both firms share a common goal of combating cigarette smoking. Kaival Brands filed a prospectus related to the offer and sale of common stock and warrants.

Catheter Precision Inc. (NYSE American: VTAK) made headlines on May 1 when it appointed Marie-Claude Jacques as its new Chief Commercial Officer. Known for its VIVOTM and LockeT cardiac electrophysiology products, the medical technology firm highlighted Jacques’ role in leading the commercialization team. On April 24, 2024, Catheter Precision reached a significant milestone with a purchase order for LockeT from HCA Healthcare Inc. (NYSE: HCA). This achievement is pivotal, given HCA Healthcare’s position as a top U.S. healthcare services provider with $64 billion in revenue in 2023.

[AveragePenny]

7 Stellar Stocks Below 5¢ Spark Investor Interest: $CLNV, $HNRC, $RSHN, $SPZI, $HALB, $ENZC, $SINT


https://thestreetreports.com/magnificent-7-stocks-under-5%c2%a2-clnv-hnrc-rshn-spzi-halb-enzc-tptw/

There are numerous stocks that consistently attract investor attention due to their core businesses and significance in the market. This article examines some of these stocks currently trading below 5 cents per share. Here are seven such stocks that investors may find worth monitoring.

Clean Vision Corporation (OTC: CLNV), a rising player in clean fuel innovation and plastic recycling, disclosed on February 20 that it secured a $15 million loan guarantee sanctioned by the West Virginia Economic Development Authority. This funding is slated to accelerate the progress of its inaugural PCN (plastic conversion network) facility in the United States, situated in Quincy under the Clean Seas West Virginia division.

Houston Natural Resources Corporation (OTC: HNRC), an oil and natural gas enterprise, revealed its financial outcomes on March 19, 2024, for the fiscal period concluding on December 31, 2023. The company reported revenues of $21,117,265, marking a 2.9% increase from the previous fiscal year. Moreover, total earnings surged by 19.3% to $11,501,687 compared to $9,641,297 in the 2022 fiscal year. As of year-end, the company’s net asset value stood at $0.42 per share.

RushNet Inc. (OTC: RSHN) recent announcement regarding Fuel Tech Inc.’s publication of a white paper detailing the successful trial of Fuel Tech’s DGI Dissolved Gas Infusion Technology at Royal Caridea’s Gila Bend, Arizona, facility. The white paper highlighted that this technology has the potential to significantly increase shrimp size while reducing production time compared to traditional methods.

Spooz Inc. (OTC: SPZI), now operating as JP 3E Holdings Inc., revealed on March 21 that it had engaged Ancell Audit & Compliance PA to audit its financial statements. The purpose of this audit, as highlighted by Spooz Inc., was to achieve full SEC reporting status, marking the initial step towards potential up-listing on the OTCQB. Ancell Audit & Compliance PA serves a diverse clientele spanning various industries, offering its services to numerous companies.

Halberd Corporation (OTC: HALB) shared on April 4th that its patented LDN+ drug had reached a significant milestone by entering the safety trial protocol within the framework of a CRADA contract designed for military personnel, both active duty and veterans. The company mentioned that the six-week safety study for the drug would encompass participation from both retired and currently active-duty volunteers.

Enzolytics Inc. (OTC: ENZC) gained attention on April 12th following its announcement about a new business direction. Steve Sharabura, the interim CEO of Enzolytics Inc., highlighted that he and the board of directors had identified specific acquisition targets and markets for implementing the company’s new strategy.

SINTX Technologies Inc. (NASDAQ: SINT) emerged as one of the top performers in today’s trading, soaring by 82% to $0.042. Earlier this month, the company priced 71,600,000 shares of its common stock at $0.021 per share, anticipating gross proceeds of about $1.5 million, excluding placement agent fees and estimated offering expenses.

[AveragePenny]

Exploring Stock Surges: Key Insights, Noteworthy Buzz: $KAVL, $PRSO, $DYAI, $WISA, $JAGX

https://thestreetreports.com/exploring-stock-surges-key-insights-noteworthy-buzz-kavl-prso-dyai-wisa-jagx/

Several companies have attracted investor attention recently due to movements in their stock prices. This article offers an in-depth analysis of five such companies.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) experienced an impressive 135% surge in its stock value on Monday amid active trading. The company is known for being the exclusive distributor of Bidi Vapor LLC products, particularly the BIDI® Stick, tailored for legal-aged nicotine users in the U.S. On March 25, Kaival Brands disclosed its financial results for the first quarter of fiscal 2024, ending on January 31, 2024. The company reported strong revenues of $3.2 million for the quarter, a notable increase from the previous year’s $2.5 million. In 2022, a significant agreement was forged with Phillip Morris Products SA (NYSE: PM) for the distribution, advancement, and development of VEEBA®, a disposable vape product, similar to BIDI® Stick. VEEBA® aims to provide convenience and simplicity for legal-aged nicotine users, offering a wide range of globally available flavors. Both companies are aligned in their mission to combat cigarette smoking.

Peraso Inc. (NASDAQ: PRSO) garnered attention on April 16 when it revealed that Panasonic System Networks R&D Lab Co. Ltd. (PSNRD) had chosen its X710 chipset for a new 60GHz WLAN solution. By integrating Peraso Inc.’s phased array antenna technology, PSNRD’s product promises low-latency communication and high-speed performance comparable to wired LAN, spanning hundreds of meters. This selection by a unit of Panasonic, a renowned global technology leader in consumer and enterprise sectors, marked a significant milestone for Peraso. The 60 GHz frequency band offers an expansive RF spectrum with advanced capabilities.

Dyadic International Inc. (NASDAQ: DYAI) In March 2024, the company released its financial results for the fiscal year 2023, with the company reporting revenues of $2,899,000 and cash, cash equivalents, and investment-level securities valued at $7.3 million at the end of the fiscal year. Additionally, the company successfully concluded a $6 million capital raise, sourced from relatives, trusts, and long-standing DYAI shareholders linked to Mark Emalfarm, the company’s CEO. This infusion has bolstered the company’s robust capital position. See Zacks Small-Cap Research Report, updated April 1, 2024. Finally, CEO Mark Emalfarb highlighted Dyadic’s accomplishments on “The Street Podcast,” highlighting the $75 million DuPont (NYSE: DD) deal and drawing parallels between Dyadic and Tesla, Inc.’s (NYSE: TSLA) transformative impact on the auto industry. Listen Now!

WiSA Technologies Inc. (NASDAQ: WISA) made headlines on April 16 with news that its subsidiary, WiSA Association, had finalized its fourth 5-year WiSA E licensing agreement with a prominent PTV/HDTV brand. According to the company’s press release, the WiSA E license allows the brand to integrate WiSA E software into its products, offering customers a range of wireless audio features. These features include compatibility with any WiSA-powered speakers from brands associated with the WiSA association. This development marked a significant milestone as the fourth HDTV brand to recognize the technology’s value and the licensing model provided by WiSA Technologies for market deployment.

On April 16, Jaguar Health Inc. (NASDAQ: JAGX) made headlines with the announcement of a 5-year licensing agreement with Venture Life Group PLC, an international consumer health company based in the UK. The agreement focuses on the oral mucusitis prescription product Gelclair, intended for the U.S. market and already approved by the FDA. While the treatment’s cost could reach up to $17,000 for patients, Gelclair offers a user-friendly, fast-acting, and durable pain relief solution.

[AveragePenny]

$KAVL Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Stock Hits 6-Month High: What’s Ahead?


https://thestreetreports.com/kaival-brands-innovations-group-inc-nasdaq-kavl-stock-hits-6-month-high-whats-ahead/

On April 15, 2024, Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) saw substantial gains, with its stock soaring by up to 135% by the day’s close. The company, known for distributing the BIDI® Stick, a disposable product containing 6% class A nicotine for a satisfying nicotine experience, utilizes advanced manufacturing and product engineering techniques. Available in various flavors nationwide, Kaival Brands may have attracted significant attention from investors due to its impressive stock performance.

Yesterday, the stock reached a new intra-day high, marking its highest point since October 2023. Currently, it is trading significantly above its 20-day and 50-day moving averages, which stand at $3.19 and $2.55, respectively. This robust performance may offer strong support for the stock in the future.

In the first quarter 2024, Kaival Brands saw revenues of $3.2 million, marking an improvement from the $2.5 million in the same quarter of the previous year. This increase in revenue was primarily due to fewer credits issued to customers. The net loss for the quarter was $2.2 million, or $0.76 per basic and diluted share, compared to a net loss of $3 million, or $1.12 per basic and diluted share, in the previous year’s quarter. The decrease in net losses was driven by higher revenues and reduced operating expenses, which totalled $2.9 million for the quarter compared to $3.5 million in the prior-year period.

In 2022, Kaival Brands made a significant move by partnering with Philip Morris International LLC affiliate Phillip Morris Products SA (NYSE: PM) to distribute and develop VEEBA®, a disposable vape product. Similar to the successful BIDI® Stick, VEEBA® aims to offer convenience and simplicity for legal-aged nicotine users, with a wide range of flavors available globally. BIDI® Stick has gained traction in Canada and numerous European countries. This agreement focused on distributing products internationally, expanding Kaival Brands’ reach beyond the United States.

The agreement was facilitated by Kaival Brands Innovations LLC, a wholly-owned subsidiary of the company. Partnering with the tobacco giant Phillip Morris (NYSE: PM) and its affiliate marked a significant expansion for Kaival Brands, propelling its presence to new heights. Both companies shared a common goal: to combat cigarette smoking.

[AveragePenny]

Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB


https://thestreetreports.com/stocks-in-the-news-in-april-2024-inbs-gevi-vtak-kavl-rlyb/

As the trading week approaches, now is an opportune moment for investors to delve deeper into companies garnering recent attention. This feature will offer insights into five such stocks.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) has shown robust performance recently, accompanied by a significant increase in trading volume. Since March 20, the stock has surged by 121% and closed at $2.95 per share on April 11, driven by a prolonged short squeeze. On March 27, the company released its financial results for the fiscal year ending January 31, 2024. Quarterly revenues rose to $3.2 million from $2.5 million in the corresponding period last year, mainly due to reduced credits issued to customers. The net loss for the quarter was $2.2 million, marking a decrease from the previous year’s net loss of $3 million.

Intelligent Bio Solutions Inc. (NASDAQ: INBS), a key player in the medical technology sector, specializes in providing fast, non-invasive, and intelligent testing solutions. Ladenburg Thalmann, a well-known Wall Street institution established in 1876, issued a buy recommendation for Intelligent Bio Solutions Inc. stock, setting a target price of $12 per share. Furthermore, on March 11, the company announced raising $10.1 million through a private placement involving accredited investors in the healthcare sector and institutional investors. On April 11, the company expanded the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, by securing a new European patent with unitary effect for its innovative DSR-Plus Cartridge Reader.

General Enterprise Ventures Inc. (OTC: GEVI) gained recognition primarily for the advancements made by its subsidiary, Mighty Fire Breaker LLC (MFB), in the field of fire-retardant solutions. In April, it was revealed that Joshua Robinson, the Chief Executive Officer of General Enterprise Ventures Inc., had returned 60% of the company’s outstanding common stock shares to the Treasury, a move expected to significantly enhance shareholder value. On April 2, news surfaced about a collaboration between SkyScout Ai Innovations and MFB’s Value-Add Wildfire Reduction Team, signaling MFB’s entry into the Canadian market with its fire-retardant product CitroTech.

Catheter Precision Inc. (NYSE American: VTAK) was highlighted in a Ladenburg Thalmann research report on April 5, 2023, with a buy recommendation and a $4 target price for the next year. On April 1, the company reported its Q4 and full fiscal year results for 2023, showing total assets of $30.7 million, a cash balance of $3.6 million, and notable revenue growth compared to the previous year. The company also reduced its net loss in the fourth quarter to $0.7 million from $8.2 million. Additionally, on April 4, Catheter Precision expanded its business development team with industry professionals to drive sales growth and market expansion.

Rallybio Corporation (NASDAQ: RLYB) gained attention on April 10 following its announcement of a collaboration with Johnson & Johnson. Under the agreement, Rallybio Corporation will assist in developing complementary therapeutic methods to reduce the risk of FNAIT (fetal and neonatal alloimmune thrombocytopenia). Additionally, Johnson & Johnson Innovations invested $6.6 million in Rallybio Corporation as part of the collaboration.

[AveragePenny]

$ASRE Form 10k - Filed 04/09/24 for the Period Ending 02/29/24

https://www.otcmarkets.com/filing/conv_pdf?id=17439026&guid=yzQ-kHlLxd1joVh

[AveragePenny]

Exploring 5 Promising Stocks: GEVI, HALB, HNRC, CLNV, SIGL

https://thestreetreports.com/exploring-5-promising-stocks-gevi-halb-hnrc-clnv-sigl/

Successful investors typically conduct thorough research and closely monitor market developments. Recently, several stocks have demonstrated significant gains, and this article offers an in-depth analysis of five such stocks.

General Enterprise Ventures Inc. (OTC: GEVI): subsidiary Mighty Fire Breaker LLC (MFB), “Tapping into Safe Fire-Retardant Chemistry” has experienced a gradual increase in trading volume recently, accompanied by a consistent upward trend. On April 2, news emerged of the MFB Value Add Wildfire Risk Reduction Team’s ongoing discussions with SkyScout AI Innovations in Vancouver, Canada, spanning several months. The collaboration aims to introduce MFB’s CitroTech product to Canada, addressing the critical need for safe fire-retardant chemistry in the region.

Halberd Corporation (OTC: HALB) “Advancing with LDN+ Drug in Military Safety Trial”, made headlines on April 4 with the announcement of a significant achievement regarding its patented LDN+ drug. The company revealed that the product had reached a crucial milestone by entering a major safety trial protocol outlined in a CRADA (Cooperative Research and Development Agreement) contract for military personnel, including active-duty members and veterans. The safety study, scheduled to last six weeks, will involve both current and retired military personnel as subjects and will commence after receiving approval from the Institutional Review Board (IRB).

Houston Natural Resources Corporation (OTC: HNRC) an undervalued oil and gas stock worth monitoring “Uncovering Value in Oil and Gas”. On March 19, 2023, Houston Natural Resources Corporation disclosed its financial outcomes for the fiscal year ending December 31, 2023. The company reported revenues of $21,117,265, marking a 2.9% increase compared to the previous year. Total earnings for the period amounted to $11,501,687, reflecting a 19.3% rise from the previous fiscal year, with earnings per share reaching $0.06.

Clean Vision Corporation (OTC: CLNV) “Accelerating Clean Fuel Development and Innovative Plastic Recycling” has witnessed a notable rise in trading volume recently, indicating a promising opportunity for investors to watch. The company, renowned for its innovations in clean fuel development and plastic recycling, announced on February 15 the approval of a $15 million loan guarantee by the West Virginia Economic Development Authority. This guarantee will expedite the establishment of Clean Vision Corporation’s first PCN (plastic conversion network) in Quincy, a significant milestone in its U.S. operations.

Signal Advance Inc. (OTC: SIGL) “Innovating Data Protection Solutions” have had a positive week, with the stock gaining 26.61%. Recently, the company introduced Analog Guard, a product designed to address consumer data protection requirements. Signal Advance Inc. highlighted Analog Guard’s unique features, allowing users to monitor the security of data storage, financial transactions, industrial controls, defense systems, and communications. Notably, Signal Advance’s stock experienced a surge in the past following misinterpreted Elon Musk’s tweet “use Signal” endorsing the Signal messaging app.

[AveragePenny]

Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements

https://thestreetreports.com/momentum-stocks-alert-dyai-kavl-vtak-nkla-atai-demonstrate-financial-growth-and-strategic-advancements/

As the trading week nears its conclusion, investors may find it opportune to assess the market landscape and delve into companies that garnered attention during this period. This piece offers insights into five stocks that merit consideration for tracking purposes.

Dyadic International Inc. (NASDAQ: DYAI) has garnered significant attention from investors over the past month, with its stock showing a 31.91% increase in value within a 30-day period through yesterday. On March 29, Dyadic International Inc. released its financial results for the fiscal year 2023. The company reported revenues of $2,899,000 for the year ended December 31, 2023, a slight decrease the previous fiscal year. However, its net loss for the year decreased to $6.8 million, or $0.24 per share, down from $9.7 million, or $0.34 per share, in the previous year. The company’s cash, cash equivalents, and investment-level securities were valued at $7.3 million at the end of the fiscal year. Also, on March 11, 2024, the company successfully concluded a $6 million capital raise, sourced from relatives, trusts, and long-standing DYAI shareholders linked to Mark Emalfarm, the company’s CEO. This infusion has bolstered the company’s robust capital position. See Zacks Small-Cap Research Report, updated April 1, 2024.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Although the pullback in the price action in the company’s stock yesterday was interesting, it should be noted that up until April 3, it had clocked gains of 98.82% in 30 days. On March 25, Kaival Brands Innovations Group Inc. announced its financial results for the first fiscal quarter ended on January 31, 2024. The revenues for the quarter went up to $3.2 million from $2.5 million in the year-ago period, and the rise was attributed to the reduction of credits issued to customers. The net loss in the quarter was $2.2 million, which reflected a drop from the net loss of $3 million in the prior year.

Catheter Precision, Inc. (NYSE-American: VTAK), a prominent player in the medical technology sector, has experienced a surge in its stock value recently, making it an intriguing option for investors to monitor closely. On April 4, Catheter Precision Inc., renowned for its cardiac electrophysiology offerings, announced a significant expansion of its business development team. The company disclosed its strategic move to bolster its sales force by recruiting seasoned industry professionals, aiming to enhance market penetration and drive further growth. Notably, this new team has successfully propelled the sales figures of an electrophysiology products firm beyond the $100 million mark.

Nikola (NASDAQ: NKLA) experienced a robust surge in its stock value on Thursday, fueled by a significant development. The uptick followed Nikola’s impressive deliveries for the first quarter of 2024, surpassing analysts’ expectations. The company delivered 40 vehicles during the quarter, exceeding the consensus estimate of 30 deliveries by four analysts. Nikola’s production during this period totaled 43 units, contributing to its positive performance.

Atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical firm focused on revolutionizing mental health disorder treatments, disclosed its financial performance for the fourth fiscal quarter and the full fiscal year ending December 31, 2023, on March 28. The company reported net losses of $18.3 million and $40.2 million for the respective periods, showcasing a significant improvement compared to the net losses of $45 million and $152.4 million in the prior-year quarter and fiscal year.